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Nucleotide sequence positions are provided with respect to the transcriptional start 
sites in the case of sRNAs, or with respect to the AUG start codon in the case of 
mRNAs (Example: +3, indicates AUG).   
Single nucleotide mutations are indicated by a “*”, followed by the respective 
nucleotide positions (Example: VqmR* (C133G)).  
Multi-nucleotide mutations of an sRNA are marked by “M#” (Example: MicV M1), 
and multi-nucleotide mutations of an mRNA are marked by “M#*” (Example: ompT 
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SUMMARY 
XII 
Summary 
 
Pathogenic bacteria such as Vibrio cholerae, the causative agent of cholera disease, thrive in 
host and non-host environments. This lifestyle requires constant monitoring of environmental 
signals to mediate adaptation through changes in gene expression. Furthermore, V. cholerae 
employs quorum sensing systems to synchronize group behaviors, such as biofilm formation 
and virulence gene expression. Both processes frequently involve regulation of gene expression 
by small regulatory RNAs (sRNAs). Bacterial sRNAs base-pair to trans encoded target mRNAs 
to alter their stability or translation. Recent studies in V. cholerae identified 107 putative sRNAs 
with yet undescribed functions. The present work aimed to characterize candidate sRNAs with 
respect to their involvement in stress responses and quorum sensing.  
  Specifically, a bioinformatical approach aiming to identify binding sites of the envelope 
stress related, alternative sigma factor σE, identified the MicV sRNA as a member of the σE 
regulon. The σE stress response of V. cholerae involves regulation by another sRNA, VrrA. 
Expression of both sRNAs is activated under high cell density conditions or by treatment with 
membrane damaging agents. Global transcriptome analyses revealed that both sRNAs act 
together to control outer membrane protein expression, and to maintain envelope homeostasis 
under membrane damaging conditions. We pinpoint collective functions of both sRNAs to the 
presence of a conserved base-pairing domain in both sRNAs. Finally, laboratory selection 
experiments employing a library of synthetic sRNAs revealed that regulation of a single porin is 
sufficient to mediate stress relief.  
  The third sRNA studied in this thesis, VadR, was identified using a genetic screen to 
assess sRNAs affecting cell curvature of V. cholerae. Analyses of the vadR promoter revealed 
that vadR expression is activated in response to cell wall damage by the VxrAB two component 
system. Transcriptome analyses revealed that VadR regulates a large gene cluster responsible 
for synthesis of the biofilm matrix, and biofilm formation was inhibited in cells overexpressing 
vadR. Additionally, we found that VadR regulates cell curvature by inhibiting translation of crvA, 
encoding the major curvature determinant of V. cholerae. Finally, we pinpoint regulation of crvA 
by VadR to be critical to mediate resistance to cell wall damage.   
  Expression of the fourth sRNA analyzed in this study, VqmR, is controlled by quorum 
sensing system, involving the autoinducer DPO. Analyses aiming to identify additional mRNA 
targets for the VqmR sRNA found five additional targets, including the low cell density master 
regulator aphA. VqmR base-pairs to aphA using an unusual site located in the rho-independent 
terminator of the sRNA. Regulation of aphA by VqmR resulted in reduced virulence gene 
expression. Finally, the present work found that the interplay of all three quorum sensing 
systems is required to achieve a full quorum sensing response.   
 
 
ZUSAMMENFASSUNG 
XIII 
Zusammenfassung 
 
Bakterielle Pathogene wie Vibrio cholerae, der Erreger der Cholera, finden sich in der Umwelt 
und in Wirtsorganismen. Dieser Lebenszyklus setzt ein konstantes Überwachen von 
Umweltsignalen voraus, um sich durch entsprechende Genexpression anzupassen. Zudem 
verwendet V. cholerae bakterielle Kommunikationssysteme um Gruppenverhalten, wie das 
Bilden von Biofilmen und die Expression von Virulenzgenen, in der Population zu 
synchronisieren. Diese beiden Prozesse beinhalten häufig die Regulation der Genexpression 
durch kleine regulatorische RNAs (sRNAs). Bakterielle sRNAs interagieren über Basen-
paarungen mit trans-kodierten mRNAs, um deren Stabilität oder Translation zu regulieren. 
Jüngste Studien haben 107 potenzielle sRNAs, mit bisher ungeklärten Funktionen, in V. 
cholerae identifiziert. Ziel der vorliegenden Arbeit war es diese sRNAs, unter Berücksichtigung 
ihrer Beteiligung an Stressantworten und bakterieller Kommunikation, zu charakterisieren.  
  Im Einzelnen wurde ein bioinformatischer Ansatz verwendet, um die Bindestellen des 
Membranstress-Sigmafaktors σE zu finden und dabei wurde die sRNA MicV als Teil des σE-
Regulons identifiziert. Die σE Stressantwort in V. cholerae beinhaltet Regulation durch eine 
weitere sRNA, VrrA. Die Expression beider sRNAs wird bei hohen Zelldichten, oder durch 
Behandlung mit membranschädigenden Substanzen, aktiviert. Transkriptomanalysen zeigten 
das beide sRNAs gemeinsam die Expression von Proteinen der äußeren Membran regulieren, 
um die Membranhomeostase unter Membranstressbedingungen zu gewährleisten. Die 
überlappenden Funktionen beider sRNAs begründen sich durch das Vorhandensein einer 
konservierten Domäne zur Basenpaarung. Abschließend zeigten wir durch 
Selektionsexperimente mit einer Sammlung von synthetischen sRNAs, dass die Regulation 
eines einzigen Porins ausreicht, um Membranstress zu lindern.   
  Die dritte sRNA in dieser Studie, VadR, wurde durch einen genetischen Screen für 
sRNAs die die Zellkrümmung von V. cholerae beeinflussen gefunden. Analysen des vadR 
Promotors zeigten das die Expression von vadR bei Zellwandstress durch das VxrAB Zwei-
komponentensystem aktiviert wird. Transkriptomanalysen zeigten das VadR ein großes 
Gencluster, verantwortlich für die Synthese der Biofilm Matrix, reguliert. Demzufolge war die 
Bildung von Biofilmen in Zellen die vadR überexprimieren inhibiert. Zusätzlich regulierte VadR 
durch Inhibieren der Translation der crvA mRNA, welche für eine wichtige Zellkrümmungs-
determinante kodiert, die Zellkrümmung. Letztendlich zeigten wir das die Regulation von crvA 
durch VadR entscheidend für die Resistenz gegen Zellwandstress ist.   
  Die Expression der vierten sRNA in dieser Studie, VqmR, wird durch ein bakterielles 
Kommunikationssystem und den Autoinducer DPO reguliert. Durch Analysen, die darauf 
abzielten neue Ziel-mRNAs der VqmR sRNA zu identifizieren, konnten fünf weitere Ziel-mRNAs 
identifiziert werden, welche unter anderem, für den Hauptregulator bei niedriger Zelldichte, 
AphA, kodieren. Die Basenpaarung zwischen VqmR und aphA ist ungewöhnlich, und benötigte 
eine Region im Rho-unabhängigen Terminator der sRNA. Die Regulation von aphA durch VqmR 
resultierte in einer Reduktion der Virulenzgenexpression. Schlussendlich konnte die vorliegende 
Arbeit zudem zeigen das drei bakterielle Kommunikationssysteme zusammenwirken, um ihre 
volle Wirkung zu entfalten.
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1.1 Vibrio cholerae, a model pathogen 
 
Cholera is a widespread and serious infectious disease, affecting an estimated 2.86 million 
patients in 69 endemic countries annually, of which 95,000 infections are fatal (1). The 
Gram-negative bacterium Vibrio cholerae was identified as the causative agent of cholera 
disease in 1854 (2).  
 Today, the literature groups V. cholerae into more than 200 serotypes, based on O-
antigen structure (3). Interestingly, only the O1 and O139 serotypes are reported to cause 
pandemic outbreaks (4–6). The O1 group is further divided into the distinct biotypes: 
“classical” and “El Tor”, and into three sub-serovars: Ogawa, Inaba, and Hikojima (7). The 
strain used in this thesis is V. cholerae C6706 and was collected by the Center for Disease 
Control and Prevention (CDC) during a pandemic outbreak in Peru in 1991, and is classified 
as O1 El Tor Inaba (8, 9). Due to their interesting life cycle, V. cholerae strains are frequently 
used as model organisms to study bacterial pathogenesis, disease transmission and gene 
regulation (10).  
 
1.1.1 The life cycle of Vibrio cholerae 
 
V. cholerae species are considered environmental pathogens and their life cycle can be 
described in three stages: the presence in aquatic environments, the entry into the human 
host, and the exit from the host and re-release into the aquatic environment (Fig. 1.1). V. 
cholerae spends the majority of its life cycle as an autochthonous inhabitant of aquatic 
environments, such as brackish and estuarial waters (11, 12). Here, V. cholerae is 
predominantly found in microbial communities called biofilms (13), that are commonly 
associated with chitinous surfaces on zoo- and phytoplankton (14, 15). Cholera infections 
occur through the uptake of contaminated food or water by the human host. V. cholerae 
utilizes a competent acid tolerance response to survive passage through the low pH 
environment of the stomach (16, 17). Of note, increased survival of V. cholerae in the 
stomach was reported, if the infection occurs through ingestion of biofilms (18). Having 
progressed to the small intestine, V. cholerae is able to attach to and penetrate the mucus 
barrier, a thick coat of complex glycoproteins, protecting the intestinal surface (19–21). 
Subsequently, V. cholerae uses the key virulence factor TCP (toxin-coregulated pilus) to 
attach to epithelial cells and initiates the production of cholera toxin (CTX) (8, 22). CTX is 
an oligomeric protein complex, consisting of one A subunit and five B subunits (23). The 
CTXB subunits specifically bind membrane receptors to mediate uptake of the toxin 
complex. Intracellular CTXA subunits stimulate adenylate cyclase activity, which activates 
chloride efflux channels, and subsequently causes severe watery diarrhea - the hallmark 
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symptom of cholera disease (24). During late-stage infections, V. cholerae initiates a 
genetic program, called the mucosal escape response, to exit the small intestine and 
disseminate in high numbers (25). V. choleraes’ persistence in these complex environments 
is largely attributable to adjustable genetic tools, that allow adaptation through changes in 
gene expression (26). These mechanisms are discussed in the following sections. 
 
Figure 1.1: Overview of the life cycle of V. cholerae: V. cholerae mainly inhabits aquatic reservoirs as free 
swimming planktonic cells, or in biofilms associated to chitinous surfaces on phyto- and zooplankton. Infection 
occurs through uptake by a human host. V. cholerae invades the small intestine, penetrates the mucus barrier, 
and attaches to epithelial cells via the TCP. V. cholerae initiates production of CTX, and multiplies in the small 
intestine. During late-stage infections, V. cholerae escapes the mucus barrier and disseminates from the human 
host through CTX-induced diarrhea.  
1.2 The role of non-coding RNA in regulating bacterial gene 
expression  
 
Bacteria must sense and respond to a variety of environmental signals, requiring efficient 
adaptation of gene expression. Bacteria respond to environmental stimuli, such as heat 
stress, nitrogen limitation, iron limitation, stationary phase growth conditions and envelope 
stress by activation of alternative sigma factors (27). These regulatory proteins associate 
with the RNA-polymerase core enzyme and direct transcriptional control towards specific 
promoters. Importantly, this mode of action restricts sigma factors to act as direct 
transcriptional activators (28). Likewise, a plethora of transcription factors sense an equally 
diverse amount of input signals and respond by activating or repressing transcription from 
specific promoter sequences (29–31).  
 Since early models predicted control of gene expression to occur entirely through 
modulating transcription, the regulatory potential of non-coding RNA was initially 
overlooked. Non-coding RNA molecules in bacteria were thought to mainly include the 
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abundant class of ribosomal RNAs (rRNA), transfer RNAs (tRNA) and other RNAs involved 
in house-keeping functions (32). While these RNAs comprise up to 95% of all transcripts in 
a bacterial cell (33), research in the past decades has unveiled an unexpected complexity 
of RNA molecules that modulate gene expression, employing a wide repertoire of distinct 
mechanisms (34).  
 Several analyses of 5’ untranslated regions (5’UTR) revealed the presence of 
riboswitches, and RNA thermometers, that modulate translation of their associated coding 
sequences, by responding to metabolites or temperature shifts, respectively (35, 36). For 
example, in V. cholerae the transcription factor ToxT activates expression of the virulence 
factor genes tcp and ctx (37). Translation of toxT mRNA is under control of a structured 
RNA element within its 5’UTR. At low temperature, intramolecular base-pairing interactions 
occlude the Shine-Dalgarno (SD) sequence within a double-stranded RNA stem-loop, thus 
preventing 30S ribosome access and resulting in low basal translation activity. At high 
temperatures, as present in the human intestine, the structure unfolds, releasing the SD 
sequence to allow ribosome access and translation of toxT (38).  
 The most prominent class of regulatory RNAs in bacteria are the so called small 
regulatory RNAs (sRNA). These sRNAs exert their regulatory function by base-pairing with 
cognate mRNAs, thus forming sRNA-mRNA duplexes. We distinguish two types of 
regulators: cis-acting and trans-acting sRNAs (discussed in the next section).   
 Cis-acting sRNAs derive from the same genomic locus as their mRNA targets - but 
in the antisense orientation - and control target gene expression by formation of RNA 
duplexes, with perfect complementarity (39). Double-stranded RNA duplexes of about 20 
base-pairs (bp), provide substrates for endoribonucleolytic cleavage by RNAse III, resulting 
in RNA duplex degradation (40, 41). The first cis-acting sRNA was discovered as part of the 
replication machinery of the plasmid ColE1 (42), and to date most cis-acting sRNAs have 
been associated with plasmids, phages, and transposons (43). Nonetheless, cis-acting 
sRNA are also found in bacterial chromosomes. In V. cholerae, translation of the mannitol-
specific transporter mtlA mRNA is controlled by the cis-acting sRNA, MtlS. In the presence 
of sugars other than mannitol, MtlS forms a 71nt long RNA duplex with the mtlA mRNA, 
occluding the SD sequence to prevent translation of the mannitol-specific permease MtlA 
(44, 45). Due to the direct proximity of the cis-acting sRNA and the mRNA target on 
opposing strands, RNA duplex formation in this, and most other cases does not require 
protein cofactors, such as Hfq (discussed below) (39, 44). Importantly, the influence of cis-
acting antisense sRNAs on bacterial gene regulation might be underestimated. This is, for 
instance, illustrated by a recent study that found that 47% of all transcriptional start sites 
(TSS) in V. cholerae initiated transcription in the antisense orientation (46).  
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1.2.1 Regulation of gene expression by trans-acting small RNAs 
 
The largest class of sRNAs are trans-acting sRNAs. These regulators derive from a wide 
range of genomic loci, including: 5’UTRs, intergenic regions (IGR) or, 3’UTRs via internal 
promoters within coding sequences (CDS), or released via endoribonucleolytic cleavage 
(34) (Fig.1.2 A-D). In contrast to cis-acting sRNAs, trans-acting sRNAs base-pair to mRNA 
targets irrespective of genomic proximity. This process is in most cases aided by the action 
of auxiliary proteins, such as Hfq (discussed below). A prototypical sRNA contains an RNA 
stem-loop on its 3’end that is followed by a stretch of Uridines (poly(U)-stretch), to facilitate 
Rho-independent transcription termination. Rho-independent terminators provide binding 
sites for the RNA chaperone Hfq and protect sRNAs against 3’ exonuclease-mediated 
decay (47, 48). Additionally, sRNAs often contain conserved, single-stranded regions to 
initiate base-pairing to target mRNAs. Due to the analogous function with their eukaryotic 
microRNA counterparts these regions are called “seed-regions” (49).   
 Trans-acting sRNAs use a wide variety of mechanisms to regulate their cognate 
mRNA targets (Fig. 1.2 E). The most common mechanism is negative regulation by 
translational repression. Here, base-pairing by an sRNA occludes the ribosome binding site 
of the mRNA target, thereby blocking accessibility to the 30S ribosomal subunit and 
inhibiting translation initiation (34). 30S ribosomal subunits have been reported to occupy a 
region of -35 to +19 nucleotides, with respect to the AUG start codon (50, 51). In general, 
this region has been reported to contain unstructured, single-stranded RNA elements (52) 
and is thus accessible for base-pairing interactions. While this mechanism of translation 
repression is sufficient to reduce protein levels, some sRNAs recruit the major endoribo-
nuclease RNase E to initiate transcript degradation (53). RNase E is composed of an N-
terminal catalytic domain and a flexible C-terminal scaffolding domain. Auxiliary proteins 
associate with the C-terminal domain of RNaseE to form a protein complex called the RNA 
degradosome (54). Interestingly, Hfq has been reported to associate with the C-terminal 
domain of RNase E, suggesting the formation of a ribonucleoprotein complex, involving 
sRNAs, Hfq, and RNase E (55). In E. coli, the SgrS and RyhB sRNAs have been reported 
to recruit an Hfq-RNase E complex towards their cognate mRNA targets ptsG and sodB to 
initiate rapid ribonucleolytic decay (55). As shown for the RyhB-sodB interaction, this decay 
is not limited to the mRNA target, but degrades the regulator, RyhB, as well – a concept 
referred to as coupled degradation (56, 57). Importantly, this mechanism ensures robust 
regulation and restricts sRNAs to act stoichiometrically (56). Due to the rapid turnover of 
sRNA and cognate mRNA target, regulation via a coupled degradation mechanism reduces 
leaky expression of target genes and is important to maintain homeostatic gene expression 
(58).  
 Importantly, trans-acting sRNAs are not restricted to interact within the tight region 
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around the start codon for efficient regulation. In S. typhimurium, the GcvB sRNA base-
pairs to a translational enhancer element within the gltI mRNA, that is located -57 to -47 
nucleotides from the start codon (59). Likewise, sRNAs can also regulate by base-pairing 
deep in the CDS. For instance, the MicC sRNA regulates ompD mRNA by base-pairing to 
a region +67 to +78 nucleotides from the start codon. Here, regulation of ompD mRNA is 
achieved by recruitment of RNase E, instead of translational repression (60).  
 Furthermore, trans-acting sRNAs are also not limited to negatively regulate their 
cognate mRNA targets. There is a wide variety of mechanisms described in which base-
pairing of an sRNA results in an activation of gene expression, in many cases involving an 
“anti-antisense” base-pairing mechanism (61, 62) (Fig. 1.2 F). For instance, in V. cholerae 
the vca0939 mRNA, encoding a diguanylate cyclase, contains an RNA stem-loop close to 
the SD sequence, which prevents 30S ribosomal access, and therefore causes low 
translation activity. The stem-loop is disrupted by base-pairing of four homologous sRNAs, 
Qrr1-4, resulting in upregulated Vca0939 protein levels (63). Interestingly, the Qrr1-4 
sRNAs employ the same seed-sequence, to downregulate hapR mRNA (64), indicating that 
sRNA seed-sequences do not determine positive or negative target regulation.  
Figure 1.2: Overview of sRNA localization and common regulatory mechanisms: (A-D) sRNAs are 
encoded in intergenic regions (A), part of the 5’UTR of associated mRNAs (B), derived from independent 
promoters in an overlapping gene (C), or generated through endoribonucleolytic cleavage of an associated 
mRNA (D). (E) Negative regulation by an sRNA is commonly enacted by Hfq-mediated base-pairing to ribosome 
binding sites (RBS), or by recruiting RNaseE to the corresponding mRNA target. (F) Hairpin structures within 
the 5’UTR can occlude the RBS, preventing efficient translation. Anti-antisense pairing by an sRNA can relieve 
this inhibition, by unmasking the RBS. 
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1.2.2 The role of RNA chaperones for trans-acting sRNAs 
 
In most bacteria the process of base-pairing between sRNAs and mRNAs is controlled by 
auxiliary proteins - in the majority of cases by the Hfq protein. Initially, Hfq was described in 
E. coli as an essential host factor required for bacteriophage Qß RNA replication (65). In 
Bacteria, Hfq is largely conserved, and found in ~50% of bacterial species (66). Hfq controls 
large and complex post-transcriptional networks, which is reflected by strong pleiotropic 
phenotypes if hfq is deleted (67). For instance, in V. cholerae hfq mutants displayed strongly 
attenuated virulence in a suckling mouse infection model (68).  
 Hfq belongs to the family of Sm-like (LSm) proteins, which perform essential tasks 
in the RNA biology of all domains of life (69). In eukaryotes, LSm family proteins control 
several processes, including: precursor mRNA splicing (70), mRNA decapping and decay 
(71), and RNA metabolism (72). In prokaryotes, the LSm family protein Hfq was reported to 
stabilize sRNAs (73), to accelerate sRNA-mRNA target annealing (74–76), and to unfold 
inhibitory RNA structures - a “classic” chaperone function (77). For instance, Hfq has been 
reported to unfold an intramolecular, double-stranded RNA structure in the OxyS sRNA, 
required for base-pairing to the rpoS mRNA (78, 79). Likewise, the interaction of the OmrA/B 
sRNAs with the dgcM mRNA requires Hfq to unfold a stem-loop in the dgcM mRNA, that 
prevents OmrA/B binding (80).  
 Hfq monomers assemble a homohexameric structure, resembling a characteristic 
donut-shape, that distinguish it from the heteroheptameric complexes formed by other LSm 
protein members (69, 81, 82). This distinctive architecture exposes four sites to the 
surrounding environment: (i) the proximal face (ii) the distal face (iii) the lateral face (the 
rim) (iv) and the C-terminal tail of variable size, which is missing in several species (83). 
These regions contain unique architectures and electrostatic surfaces, allowing them to 
discriminate between different RNA species (84–86). The proximal face preferentially 
interacts with poly(U) (Uridine) sequences, as found in Rho-independent transcription 
terminators, and ubiquitous in Hfq binding sRNAs (87–89). The preferential binding to 
transcription terminator structures is illustrated by the frequently observed enrichment of 
mRNA 3’UTRs in Hfq co-immunoprecipitation experiments (90, 91). The distal face of Hfq 
preferentially binds to A (Adenosine)-rich sequences in both sRNAs and mRNAs, often 
containing a canonical A-R-N (where R represents a purine (A or G (Guanosine) and N 
represents any nucleotide) motif (92–95). The lateral face contains secondary binding sites 
for UA-rich sequences and is required for several interactions of both sRNAs and mRNAs 
(94). Due to its intrinsically disordered nature, the C-terminal tail of Hfq was not resolved in 
initial Hfq crystal structures and its function remained unclear. But recent studies propose 
that the C-terminal tail displaces weakly bound sRNAs, thus achieving selective binding 
(96–98). According to these observations, Hfq-interacting sRNAs can be classified by two 
CHAPTER 1: INTRODUCTION 
8 
different modes of interaction with Hfq. Class I sRNAs, bind to the proximal face of Hfq, and 
base pair with cognate, distal-face-binding mRNA targets. Class II sRNAs, can bind both 
the proximal and distal face of Hfq, and base-pair to lateral face-binding mRNAs (86, 94). 
According to the different binding sites on Hfq, Class I sRNAs have been reported to turn-
over rapidly, while Class II sRNAs have been reported to be more stable (94).  
1.2.3 Identification and characterization of small RNAs in bacteria  
 
In 1984, Mizuno et al. identified the first sRNA-mRNA pair by chance, while characterizing 
ompC promoter fragments. The researchers observed a strong downregulation of OmpF 
protein levels, when a 300 bp DNA fragment - encoding the MicF sRNA - was introduced 
into E. coli, on a plasmid (99). This observation motivated a series of follow-up studies, 
aiming at the identification of novel sRNAs on a genome-wide scale. In E. coli, a screen 
predicting promoter and terminator locations with limited space separation, and taking 
phylogenetic conservation into account, yielded 14 novel sRNAs derived from IGRs (100). 
One drawback of these computational sRNA studies was the limited transferability to less 
well-characterized species, for example, due to missing promotor consensus motifs (101). 
This emphasized the need for unbiased approaches to experimentally identify bacterial 
sRNAs (102). For example, the usage of high-density tilling microarrays was adapted from 
the usage in E. coli (103) to distantly related bacteria (104, 105). Modern methods for sRNA 
identification employ high-throughput sequencing to a large extent. For example, deep-
sequencing approaches have been used to identify the global sRNA ligands bound to the 
RNA chaperone Hfq in S. typhimurium (90, 106). Furthermore, the use of differential RNA-
seq (dRNA-seq), a method that allows to distinguish between primary and processed 
transcriptomes has been developed as an elegant method to map transcriptional start sites 
(TSS), by selective sequencing of primary transcripts. To achieve this, total RNA samples 
are split into pairs, and treated with terminator exonuclease (TEX), or left untreated. TEX 
treatment selectively depletes processed, 5’-monophosphate (5’-P) carrying transcripts 
from the sample, so that primary transcripts, carrying a 5’-triphosphate (5’-PPP), become 
enriched. Subsequently, complementary-DNA (cDNA) libraries are generated from the 
samples and subjected to high-throughput sequencing. Primary transcripts and sRNAs are 
then identified through the enrichment in TEX treated samples. Vice versa, processed 
sRNAs are detected through the depletion in TEX treated samples (107). While initially 
applied to Helicobacter pylori (108), the method has been broadly adapted to numerous 
bacterial species (109). In V. cholerae, the application of dRNA-seq identified 7,240 TSS 
and 107 novel sRNAs (46).  
 While the listed approaches can successfully identify novel sRNAs, they don’t 
necessarily inform about their physiological roles. Since sRNA gene deletion approaches 
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rarely yield strong phenotypes, a straightforward way to gain insight into their biological 
roles is the identification of their respective mRNA targets (110, 111). Numerous 
approaches exist to achieve this goal. First, state-of the art computational approaches, that 
account for complementarity, phylogenetically conserved interactions, and necessarily 
accessible interaction sites, have successfully identified mRNA targets (112, 113). 
Nonetheless, these in silico approaches can suffer high false-positive rates (114). Second, 
scoring changes in global transcript abundance by RNA-seq after induction of a short burst 
of sRNA overexpression - referred to as pulse-induction - has successfully captured mRNA 
targets, since rapid transcript degradation is often a consequence of translational inhibition 
by sRNAs (111). For instance, a pulse-induction approach unveiled a whole network of 
sRNA-mRNA interactions for the RybB sRNA, downregulating multiple mRNAs encoding 
outer membrane proteins (115). Third, recent developments in the field of eukaryotic 
microRNA (miRNA), have employed ligation of miRNA-mRNA pairs bound to the RNA-
binding Argonaut protein (116–118). This inspired several approaches to transform this 
methodology to RNA-binding proteins in bacteria (119). To name one such approach, the 
application of RNA interaction by ligation and sequencing (RIL-seq), has unveiled 2,800 
putative sRNA-mRNA interactions occurring on E. coli Hfq (120). An important limitation of 
RIL-seq approaches is the strict requirement for an RNA binding protein (121). While a 
breadth of approaches listed here allow the analysis of bacterial sRNA interactomes in a 
top-down manner, they still require validation experiments. Further analysis of sRNA 
expression and identification of the involved transcription factors is needed to deduce 
physiological roles.  
1.3 Involvement of sRNAs in bacterial stress responses  
 
During their life cycle, V. cholerae and related bacteria encounter diverse environmental 
stress signals, such as: temperature fluctuations, salinity shifts, nutrient availability, 
protozoan grazing, phages, pH shifts, reactive oxygen species, bile salts and antimicrobial 
peptides (122).  
  In many cases, the first interaction site between bacteria and these environmental 
signals is the bacterial cell envelope. The envelope allows bacteria to selectively transport 
small molecules, such as nutrients or autoinducers (discussed below), while excluding toxic 
molecules, such as antibiotics (123, 124). In Gram-negative bacteria the envelope is 
composed of the outer membrane, the periplasm, a layer of peptidoglycan and the inner 
membrane (125). Maintaining the integrity of the envelope is critical for cell survival and is 
therefore tightly controlled. Enterobacteria have evolved adequate stress response 
systems, that monitor insults to the envelope and mitigate stress by adapting gene 
expression accordingly (126). There are five stress response systems described, that 
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respond to various stressors to the Gram-negative cell envelope: (i) the Psp (phage shock 
protein) stress response, activated by disruption of the proton motive force in the inner 
membrane (ii) the Bae (bacterial adaptive response) stress response, activated by exposure 
to toxic molecules (iii) the Rcs (regulator of capsule synthesis) stress response, responding 
to peptidoglycan and lipopolysaccharide damage (iv) the Cpx (conjugative plasmid 
expression) stress response, responding to misfolded or delocalized inner membrane 
proteins (v) and the σE-dependent stress response, activated in response to misfolded outer 
membrane proteins (OMPs) (127). Importantly, the downstream reactions facilitated by 
these major stress responses often involve regulation by one or more sRNAs to rapidly 
alleviate stress (128).   
 One of the best studied examples is the σE-dependent stress response of E. coli and 
related enterobacteria (Fig. 1.3). In the absence of outer membrane damage (e.g. during 
exponential phase growth conditions), the alternative sigma factor σE is kept inactive by 
direct interaction with its corresponding, inner-membrane associated, anti-sigma factor 
RseA (129, 130). Accumulation of toxic, misfolded OMPs (e.g. during stationary phase 
growth conditions) in the periplasm activates the inner-membrane associated protease 
DegS, inducing a conformational change to enable cleavage of the periplasmic domain of 
RseA (131). To ensure specific σE activation under inducing conditions, the periplasmic 
domain of RseA is additionally protected from proteolysis by interaction with RseB (132). 
While the exact molecular mechanism remains elusive, the RseA-RseB interaction is likely 
disrupted by interaction with off-pathway lipopolysaccharides (133) or misfolded OMPs 
(132), under inducing conditions. Cleavage of the periplasmic domain of RseA, renders the 
protein accessible for proteolytic attack by a second protease, RseP, subsequently cleaving 
its transmembrane domain (134, 135). The remaining cytoplasmic fragments of RseA are 
cleaved by the cytoplasmic protease ClpXP and the released σE recruits RNA polymerase 
core enzyme to activate its regulon (136). The σE regulon comprises protein chaperones to 
assist with OMP folding, proteins involved in the insertion of OMPs into the outer membrane, 
and proteases to degrade misfolded OMPs (137). Additionally, σE activates expression of 
three sRNAs, MicA (138), RybB (115), and MicL (139). MicL specifically downregulates 
expression of a single mRNA, lpp, encoding the most abundant protein of E. coli (139). In 
contrast, MicA and RybB control large regulons to stop de novo synthesis of major OMPs 
upon σE induction, thereby allowing the restoration of envelope homeostasis (140, 141). 
While the protein components of the σE stress response are largely conserved, V. cholerae 
encodes no direct homologous of the MicA, RybB and MicL sRNAs (142, 143). Instead, an 
evolutionary unrelated σE-dependent sRNA, VrrA, has been reported to control expression 
of the major porins OmpA, OmpT, the ribosome hibernation protein Vrp, and the biofilm 
matrix protein RbmC (142, 144–146). Interestingly, the interaction of VrrA with ompA mRNA 
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has been reported to be independent of the RNA chaperone Hfq, but ompA mRNA levels 
were increased in hfq mutants (142). Furthermore, the σE-response and several additional 
porins are deregulated in V. cholerae hfq and rpoE mutants (68), together suggesting 
potential regulation by a yet undescribed σE-dependent sRNA. The present work addresses 
this hypothesis by functional characterization of the sRNA arm of the σE-response of V. 
cholerae in Chapter 2. 
 
Figure 1.3: Overview of the σE mediated envelope stress response of E. coli and V. cholerae: The σE-
response is activated by accumulation of misfolded OMPs in the periplasm, and off-pathway LPS, which induce 
a proteolytic cascade in the inner membrane. Consecutive cleavage of the DegS, RseP, and ClpXP proteases 
cleaves the anti-sigma factor RseA, resulting in the release of σE. Free σE activates expression of a protein arm 
for outer membrane repair and an sRNA arm to rapidly halt OMP de novo synthesis. In E. coli, the sRNAs RybB 
and MicA inhibit the expression of large regulons, comprising all major OMPs and several related targets. The 
MicL sRNA specifically downregulates lpp expression. In V. cholerae, the functionally homologous sRNA VrrA 
inhibits translation of the ompT and ompA mRNAs. The figure was adapted and modified from: (128, 147) 
 Another key system to maintain envelope homeostasis, the Rcs stress response, is 
activated by damage to the peptidoglycan layer or LPS, for instance upon encountering cell 
wall acting antibiotics or cationic antimicrobial peptides (148, 149). The Rcs system is 
reported to control production of exopolysaccharide biosynthesis, biofilm formation, and 
motility in E. coli (150–152). In addition, the Rcs system activates expression of the RprA 
sRNA (153). Subsequently, RprA activates translation of rpoS through an anti-antisense 
pairing mechanism (154). The rpoS gene encodes the stationary phase sigma factor σS, 
that controls the general stress response, and provides cross-protection from several 
stresses (155). For instance, the Rcs system has been shown to be critical for recovery of 
cell shape, if the cell-wall has been artificially removed by lysozyme treatment (156).   
 Interestingly, V. cholerae is remarkably tolerant to similar treatments, and fails to 
lyse under beta-lactam induced cell wall damage, although no homologs of the Rcs 
response related proteins exist in V. cholerae (157). Instead of the Rcs system, recovery 
from cell wall damaging conditions is mediated by the VxrAB (a.k.a. WigKR) two component 
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system. The VxrAB regulon is activated by penicillin G treatment and activates expression 
of cell wall biosynthesis genes (158), controls host colonization and Type VI secretion (159), 
and biofilm formation (160). Although sRNA-based regulation plays a key role in related 
stress response systems and it has been speculated that each bacterial regulon contains 
at least one sRNA (161), no homolog of RprA is known in V. cholerae, and no sRNA has 
been associated to the VxrAB regulon. The present work addresses the involvement of 
sRNA-based regulation in the VxrAB response in Chapter 3.  
1.4 Involvement of sRNAs in bacterial communication systems 
 
In addition to the above mentioned responses, bacteria use a process called quorum 
sensing (QS) to efficiently interact with the environment as a group (162). QS allows 
bacteria to distinguish and count members of their own species apart from others, through 
the synthesis, export, and subsequent detection of small molecules, called autoinducers 
(163). In V. cholerae, QS directly controls synchronization of group behaviors, such as 
biofilm formation and virulence gene expression (18, 164, 165).  
 The canonical QS system of V. cholerae involves production of the autoinducers 
CAI-1 and AI-2 by the synthases, CqsA and LuxS, respectively (166, 167) (Fig 1.4). Under 
low cell density conditions, when autoinducer concentrations in the environment are low, 
the autoinducer receptor proteins CqsS and LuxPQ phosphorylate the LuxU protein. The 
phosphate signal is transferred to the transcription factor LuxO, which, in complex with the 
alternative sigma factor σN, activates the expression of four homologous sRNAs, called 
Qrr1-4 (Quorum regulatory RNA) (64). The Qrr1-4 sRNAs have been reported to collectively 
control expression of 20 mRNAs (168). Importantly, the Qrr1-4 sRNAs use an “anti-
antisense” base-pairing mechanism to unfold an inhibitory RNA stem-loop in the 5’UTR of 
aphA, thereby activating aphA translation (169). The aphA mRNA, encodes the master 
regulator of low cell density functions AphA, that has been reported to control expression of 
300 genes, involved in virulence and biofilm formation (170). Conversely, the Qrr1-4 sRNAs 
inhibit hapR translation by base-pairing to a region close to the Shine-Dalgarno sequence 
(64). The hapR mRNA, encodes the master regulator of high cell density functions HapR, 
that has been reported to control expression of 100 genes, for example involved in 
chemotaxis and motility (25, 171). Importantly, HapR activates expression of the Hap 
protease, required for host escape (172). In summary, the Qrr1-4 sRNAs function at the 
center of the QS system to tune expression of the key regulators AphA and HapR, 
controlling virulence gene expression and host escape functions (170). Under high cell 
density conditions, autoinducer-binding to CqsS and LuxPQ induces a conformational 
change, converting the receptors to phosphatases. In turn, CqsS and LuxPQ 
dephosphorylate LuxU, resulting in a de-repression of hapR and thus inhibiting virulence 
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gene expression and biofilm formation (173).  
  Recently, a third quorum sensing circuit has been established in V. cholerae. Here, 
the Tdh enzyme catalyzes synthesis of the autoinducer DPO (Fig. 1.4). DPO is sensed by 
the transcriptional regulator VqmA, which subsequently activates expression of the VqmR 
sRNA (174). The regulon for the VqmR sRNA has been established, and involves, among 
other mRNA targets, the vpsT mRNA, encoding the key regulator of biofilm matrix 
production (46, 175). Importantly, the initial transcriptome analysis to identify the VqmR 
regulon was conducted under high cell density conditions using microarrays (46). 
Considering the limited dynamic range of microarrays (176), and that VqmR has been 
shown to be expressed in exponential phase of bacterial growth (174), we aimed to identify 
additional targets for the VqmR sRNA in Chapter 4. To this end, we performed transcriptome 
analysis under low cell density conditions using RNA-seq.  
 
 
Figure 1.4: Overview of the quorum-sensing systems of V. cholerae: Quorum sensing in V. cholerae 
involves the synthesis, detection, and response to the three autoinducers CAI-1, AI-2, and DPO. CAI-1 and AI-
2 are synthesized by CqsA and LuxS, respectively. DPO is synthesized by Tdh. Under low cell-density 
conditions, CqsS and LuxPQ channel phosphate through LuxU to LuxO. Phosphorylated LuxO activates 
expression of the Qrr1-4 sRNAs. The Qrr1-4 sRNAs collectively activate expression of aphA, while inhibiting 
translation of hapR. AphA activates expression of virulence gene expression and biofilm formation through 
VpsT. Presence of autoinducers under high cell density conditions, converts CqsS and LuxPQ to phosphatases, 
resulting in dephosphorylation of LuxU. This leads to de-repression of hapR expression and reduced virulence 
gene expression. DPO is sensed by its cognate receptor VqmA. VqmA activates expression of the VqmR sRNA, 
which inhibits translation of the vpsT mRNA. The figure has been adapted and modified from: (177) 
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1.5 Aim of the study 
 
The key objective of this thesis was the identification and functional characterization of 
regulatory small RNAs involved in stress responses and quorum sensing in the human 
pathogen V. cholerae. While sRNAs and their cognate regulons have been extensively 
studied in model organisms such as E. coli and S. typhimurium, only few studies in distantly 
related pathogens exist (178). Importantly, the evolution of sRNAs is thought to occur 
rapidly and often prevents identification of sRNA homologs between species (161). Direct 
transfer of the obtained knowledge from model species to other bacteria is thus challenging, 
and further complicated by the observation that homologous sRNAs frequently show 
different expression patterns and control different regulons (179, 180). For instance, while 
both V. cholerae and S. typhimurium encode homologs of the GcvB sRNA, their expression 
patterns differ. In S. typhimurium, GcvB shows high expression in exponential growth 
phase, and low expression in stationary growth phase (59). In V. cholerae this trend is 
inversed (46). Furthermore, while both E. coli and V. cholerae encode significantly similar 
(identical at 31 of 34 nucleotides in the core region) copies of the RyhB sRNA, their regulons 
are different (181). Although some examples of homologous sRNAs between E. coli and V. 
cholerae exist, the majority of V. cholerae sRNAs remain uncharacterized.  
 A recent dRNA-seq approach identified 107 novel sRNA candidates in V. cholerae 
(46). The key aim of this thesis was to investigate these candidate sRNAs with respect to 
their transcriptional regulation, their regulons, and their physiological roles. We addressed 
these questions in the following chapters:  
  In Chapter 2, a screen for sigma factor binding sites in the promotor regions of the 
107 candidate sRNAs should be used to investigate potential involvement in V. cholerae 
envelope stress response. Identified candidates should be investigated with respect to their 
regulons and physiological roles under membrane stress conditions.  
  In Chapter 3, a plasmid library, overexpressing candidate sRNAs, should be used 
to identify candidate that affect V. cholerae cell shape. Identified candidates should be 
investigated concerning their physiological roles, transcriptional control, and mRNA targets, 
and their potential involvement in bacterial stress responses.  
  In Chapter 4, the VqmR sRNA should be investigated for additional mRNA targets. 
Since previous approaches aimed to identify mRNA targets under high-cell density (46), the 
conditions should be altered by probing low-cell density conditions. 
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Abstract  
Bacteria employ remarkably sophisticated mechanisms to control their cell shape and size. 
Vibrio cholerae, the causative agent of cholera disease, exhibits a characteristic curved rod 
morphology, which promotes infectivity and motility in dense hydrogels. The periplasmic 
protein CrvA determines cell curvature in V. cholerae, yet the regulatory factors controlling 
CrvA are currently unknown. In this study, we discovered the VadR small RNA (sRNA) as 
a post-transcriptional inhibitor of the crvA mRNA. Mutation of vadR increases cell curvature, 
whereas over-expression has the inverse effect. We show that transcription of vadR is 
activated by the VxrAB two-component system and triggered by cell-wall-targeting 
antibiotics, such as penicillin G. V. cholerae cells failing to repress crvA by VadR display 
strongly decreased survival upon challenge with penicillin G indicating that cell shape 
maintenance by the sRNA is critical for antibiotic resistance. VadR also blocks the 
expression of various key biofilm matrix genes and thereby inhibits biofilm formation in V. 
cholerae. Thus, VadR is an important regulator for synchronizing peptidoglycan integrity, 
cell shape, and biofilm formation in V. cholerae. To our knowledge, VadR is the first sRNA 
required for resistance towards ß-lactam antibiotics and the first sRNA regulator controlling 
cell shape in bacteria. 
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MAIN TEXT 
Bacterial cell shape is highly diverse and tightly conserved at the species level. Certain cell 
morphologies have been associated with distinct physiological functions such as optimized 
nutrient uptake, efficient surface adherence, and increased evasion from protist grazing1. 
Cell shape is determined by the geometry of the cell-wall, which can be affected by 
filamentous protein factors that change or interfere with peptidoglycan insertion2-4. For 
example, the cytoskeleton-like filament, crescentin (CreS), controls cell curvature in the 
model bacterium Caulobacter crescentus5. In Vibrio cholerae, CrvA protein polymerizes in 
the periplasmic space to promote cell bending6,7. V. cholerae cells lacking the crvA gene 
display attenuated colonization in animal infection models and it has been reported that cell 
curvature of V. cholerae increases in a cell-density dependent manner6. These findings 
indicate that CrvA levels is continuously adjusted during growth, however, the necessary 
regulatory factors are currently unknown.   
  Recently, post-transcriptional control by small regulatory RNAs (sRNAs) in V. 
cholerae was shown to be key for modulating spatiotemporal processes such as virulence, 
biofilm formation, secondary messenger production, and stress resistance8-11. The largest 
class of sRNAs associates with the RNA chaperone Hfq and typically regulate the 
expression of target mRNAs by base-pairing via short stretches of imperfect 
complementarity12,13. The network regulated by a single sRNA frequently involves dozens 
of targets and therefore sRNAs can rival transcription factors with respect to their regulatory 
scope and biological importance14. For example sRNAs are crucial for iron, membrane, and 
sugar homeostasis, as well as motility, biofilm formation, and virulence15,16, however, no 
sRNA has been yet reported to control cell shape.   
  Here, we employed the curved rod-shaped bacterium V. cholerae as a model system 
to study the impact of sRNAs on cell curvature. To this end, we used a forward genetic 
screen and quantified the effect of 21 previously uncharacterized Hfq-dependent sRNAs on 
cell shape in V. cholerae. We discovered that production of the VadR (VxrB activated small 
RNA, see below) sRNA efficiently reduced cell curvature in V. cholerae by inhibiting the 
expression of the crvAB mRNA at the post-transcriptional level. VadR also controls several 
main genes required for biofilm assembly, including rbmA17. Consequently, we show that 
VadR also inhibits biofilm formation in V. cholerae. We further show that transcription of 
VadR is controlled by the VxrAB two-component system (a.k.a. WigKR18,19) and is activated 
by ß-lactam antibiotics. V. cholerae mutants deleted for vadR display increased sensitivity 
towards penicillin and we pinpoint this phenotype to VadR-mediated repression of crvAB. 
Our results reveal how a non-coding RNA involved regulates a cytoskeleton-like filament in 
bacteria and establishes a link between cell shape, biofilm formation, and antibiotic 
resistance in V. cholerae.  
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RESULTS 
To identify sRNAs regulating cell curvature in V. cholerae, we performed a microscopy-
based forward genetic screen. We selected 21 uncharacterized sRNAs candidates from a 
pool of recently identified Hfq-dependent sRNAs20 and cloned their respective genes onto 
multi-copy plasmids. We transferred these plasmids into V. cholerae and assayed the 
resulting strains for centerline curvature using phase contrast microscopy. In line with a 
previous report6, we found that curvature decreased ~3-fold in crvA deficient cells, when 
compared to wild-type V. cholerae (Fig. 1a). Over-expression of 20 sRNAs did not render 
curvature significantly, however, cells overexpressing one sRNA, which we term VadR 
(a.k.a. Vcr09020, see below), displayed ~2-fold reduced curvature (Fig. 1a).   
The vadR gene is located on the plus strand of the smaller V. cholerae chromosome 
between the vca0002 and vca0003 genes20. The sRNA is present in numerous other Vibrios 
and carries a highly conserved 5’ end (Fig. 1b) frequently involved in RNA duplex formation 
with trans-encoded target mRNAs8,21. Structure probing experiments confirmed that this 
region is unstructured and therefore available for base-pairing with other transcripts (Figs. 
S1a-b). Northern blot analysis revealed that VadR accumulates as a ~85 nt transcript and 
is most highly expressed at low cell densities (Fig. 1c). Stability of VadR was ~3 min in V. 
cholerae wild-type cells and ~4-fold reduced in cells lacking the hfq gene (Fig. S1c). 
Together, we conclude that VadR is a Hfq-dependent sRNA that is likely to act by base-
pairing other transcripts.   
  Alignment of vadR promoter sequences revealed three conserved elements 
upstream the -10 box (Fig. 1b). While we were unable to directly assign a transcriptional 
regulator to these elements, we discovered that a vadR transcriptional reporter was ~150-
fold more active in V. cholerae when compared to Escherichia coli (Fig. S1d). These results 
suggested that vadR expression depended on a V. cholerae-specific factor, which allowed 
us to perform another genetic screen. Here, we employed a plasmid library expressing ~2.5 
kb V. cholerae genomic fragments, which we co-transformed with a PvadR::lacZ 
transcriptional reporter into E. coli. We assayed ~23,000 colonies for ß-galactosidase 
activity on plates containing X-gal and isolated seven blue colonies. Sequence analysis of 
the respective plasmids revealed that all mapped to the vxrABCDE (vca0565-0569) locus; 
five plasmids contained sequences of vxrAB and two plasmids contained sequences of 
vxrABCDE (Fig. S1e). To corroborate these results, we monitored vadR production in wild-
type and ∆vxrABCDE V. cholerae by means of (i) promoter activity measurements and (ii) 
Northern blot analysis. Indeed, promoter activity was ~50-fold reduced in the vxrABCDE 
mutant (Fig. S1f) and VadR was no longer detectable on Northern blots (Fig. 1d). 
Successive complementation of the vxrABCDE genes from a plasmid revealed that vxrAB 
(constituting the histidine kinase and response regulator of the two component system, 
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respectively) restored VadR expression, while vxrCDE were dispensable for regulation (Fig. 
1d). Finally, to pinpoint direct regulation of vadR by VxrB, we reanalyzed previously reported 
ChIP-Seq data22 for binding of VxrB at the vadR promoter. Indeed, we discovered a 
pronounced, VxrB-specific peak upstream of the vadR gene (Fig. S1g). These analyses 
also revealed a putative VxrB binding motif (TTGACAAAA-N2-TTGAC), which matched the 
three conserved sequence elements in the vadR promoter (Fig. 1b). Deletion of each of 
these sites efficiently reduced vadR promoter activity with sites 2 and 3 being most critical 
for transcription activation (Fig. S1h). Together, we conclude that VadR is a VxrAB-activated 
sRNA that modulates cell shape in V. cholerae.   
  To explore the molecular mechanism of VadR-mediated inhibition of cell bending, 
we next aimed to identify base-pairing partners of VadR in vivo. We used RNA-seq analyses 
to assess changes in global transcriptome levels following transient (15 min) 
overexpression of vadR in a  ∆vadR V. cholerae strain. In total, 28 mRNAs, including crvA, 
displayed significant changes following VadR expression (Fig. 2a and Table S1). We 
validated regulation of all targets, except ibpA, using quantitative real-time PCR (by testing 
all monocistronic genes and the first gene of all regulated operons; Fig. S2a). The majority 
of repressed targets (15) corresponded to a single biofilm gene cluster (vc0916-vc0939) 
required for the production of the VPS biofilm exopolysaccharide, as well as genes 
producing the auxiliary biofilm components, RbmA-F23 (Fig. 2b). Gene ontology (GO) 
analyses revealed a significant overrepresentation of GO terms associated with 
polysaccharide synthesis in the downregulated targets (Fig. 2c). Indeed, using the wrinkly 
colony morphology phenotype of V. cholerae ∆hapR cells as a read-out for biofilm 
formation20, we discovered that VadR over-expression resulted in strongly decreased 
biofilm formation (Fig. 2d). This phenotype was further corroborated by quantitative 
measurements of biofilm formation in microfluidic flow chambers, analyzed by confocal 
microscopy (Figs. 2e-h). Detailed analysis of the respective microscopic images revealed 
that VadR expression resulted in a phenotype mimicking V. cholerae cells lacking the rbmA 
gene (Figs. 2e-i). RbmA is required to form higher order structures in V. cholerae biofilms 
and depletion of the protein from the biofilm results in decreased biofilm density17,24,25. 
Indeed, we observed a significant reduction in local biofilm density in cells over-expressing 
VadR (Figs. 2f, i), which is consistent with reduced RbmA levels determined by quantitative 
Western blots (Fig. S2b). These results show that in addition to controlling cell shape, VadR 
also regulates biofilm formation in V. cholerae.  
  To investigate the molecular underpinnings of VadR-mediated gene control in V. 
cholerae, we cloned the 5’ UTR (untranslated region) and the TIR (translation initiation 
region) of the 14 potential VadR targets into a GFP-based reporter plasmid designed to 
score post-transcriptional control26. Co-transformation of these plasmids with a VadR over-
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expression vector or a control plasmid in E. coli confirmed post-transcriptional repression 
of nine targets (crvA, irpA, rbmA, rbmD, vpsL, vpsU, vc2352, vca0075, and vca0864), while 
we were unable to validate direct regulation of bapI, rbmC, rbmF, rbsD, and vca0043 (Figs. 
3a and S3a). Using the RNA hybrid algorithm27, we predicted RNA duplex formations of 
VadR with crvA, rbmA, vpsU, and vpsL (Figs. 3b-e). In all four cases, pairing involved the 
target’s TIR and sequence elements located in the first 30 nucleotides of VadR. Using 
compensatory base-pair exchange experiments (creating mutants M1, M2, and M3 in vadR, 
see Figs. S1a and S3), we validated binding at the predicted positions (Figs. 3f-i). To bolster 
these results at the phenotypic level, we tested biofilm formation of ∆vadR cells expressing 
a mutated VadR variant (VadR∆R1, see Figs. S1a and S3b) unable to repress three of the 
four target genes. In contrast to wild-type VadR (Figs. 2d, f), VadR∆R1 did not affect biofilm 
formation and architecture in V. cholerae (Fig. 2d, g, i).   
  Given that we confirmed VadR as a direct repressor of crvA (Figs. 3b, f), we next 
aimed to study the role of VadR in cell curvature in V. cholerae. Western blot analysis 
showed CrvA levels were ~1.5-fold elevated in ∆vadR cells, whereas VadR over-expression 
led to a ~2-fold reduction in CrvA production (Fig. 4a). We correlated these results with 
microscopic curvature analyses of single cells and discovered that vadR-deficient mutants 
displayed increased curvature, whereas plasmid-borne VadR production had the reverse 
effect (Figs. 4b top and 4c). This effect was further amplified when cells were treated with 
sub-inhibitory concentrations of cefalexin forcing filamentation in V. cholerae (Fig. 4b, 
bottom). Importantly, neither vadR deletion, nor its over-expression affected cell length or 
volume of V. cholerae (Figs. S4a-b), indicating that VadR specifically modulates cell 
curvature by inhibiting crvA expression.   
  CrvA regulates cell curvature by spatially modulating peptidoglycan insertion in V. 
cholerae6 and the VxrAB regulon is induced by peptidoglycan-targeting antibiotics such as 
penicillin G19. Consequently, we tested the effect of penicillin G on VadR expression. 
Indeed, Northern blot analysis showed ~7-fold increased VadR levels in V. cholerae wild-
type cells following treatment with penicillin G (Fig. 5a) and we observed ~25-fold induction 
when we tested vadR promoter activity using a transcriptional reporter (Fig. 5b). In both 
cases, penicillin G-dependent activation of vadR was abrogated in the ∆vxrABCDE strain 
(Figs. 5a-b). Expression of vadR was also activated by the MreB-targeting antibiotic A2228, 
albeit to a lower extent when compared to penicillin G (Fig. S5a).    
  Based on these results, we speculated that resistance towards cell-wall damaging 
antibiotics requires the remodeling of cell shape-determining components by VxrAB and 
VadR. Following this hypothesis, we first determined the relationship between CrvA 
production and penicillin G resistance. To this end, we cloned the inducible pBAD promoter 
upstream of the chromosomal crvAB gene in V. cholerae and activated expression for 1.5h 
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using various concentrations of L-arabinose. Next, we added penicillin G and continued 
incubation for additional 3 h when we determined survival by counting colony-forming units 
on agar plates. Indeed, we obtained ~2-fold fewer colony counts at low L-arabinose 
concentrations (0.0125% final conc.) and up to ~3.5-fold reduced colonies when the 
promoter was strongly induced (0.05% final conc.) (Fig. S5b). These data indicated that 
elevated CrvA levels impair penicillin G resistance in V. cholerae. In accordance with this 
observation, we also discovered reduced penicillin G survival rates for vadR-deficient V. 
cholerae cells and we were able to complement this phenotype using plasmid-borne VadR 
production (Fig. 5C). To pinpoint this effect to VadR-mediated repression of crvA in the 
presence of penicillin G, we introduced mutation M1* (Fig. 3b) at the chromosomal crvA 
locus. This mutation keeps crvA production intact (Fig. S5c), but renders the transcript 
immune towards post-transcriptional repression by VadR. This strain phenocopied the 
effect of a vadR mutant. We obtained almost identical results when we introduced the 
corresponding mutation (M1, Figs. 3b and S1a) at the chromosomal vadR gene (Fig. 5C). 
Combination of the two mutant alleles resulted in a partial restoration of penicillin G 
resistance (Fig. 5C), supporting our initial hypothesis that VadR is required to mitigate the 
detrimental effect of CrvA under antibiotic pressure. Notably, neither mutation nor over-
expression of vadR affected survival of V. cholerae under standard growth conditions (Fig. 
S5d).   
  To connect the roles of VadR in cell curvature regulation and biofilm formation in V. 
cholerae, we monitored VadR expression (using a PvadR::mRuby2 transcriptional reporter) 
in growing biofilms employing single-cell confocal microscopy analysis29. When normalized 
for sfGFP production driven from the constitutive Ptac promoter, we discovered that the vadR 
promoter is most active during the initial phases of biofilm formation, while expression is 
switched off in mature biofilms (Fig. 6a). In parallel, we also determined cell curvature of 
individual cells during biofilm development (Fig. 6b). Comparison of the two datasets 
showed that VadR expression and cell curvature are negatively correlated (Fig. 6c), 
suggesting that VadR expression results in straighter cells during early phases of biofilm 
development, whereas mature biofilms are more likely to contain a higher proportion of 
curved cells.   
  Given that VadR also controls the production of several mRNAs encoding important 
biofilm factors such as VPS, RbmA, RbmC and Bap1 (Fig. S2a), it seems possible that 
VadR also limits the expression of these components in early biofilms (Fig. 6d). 
Transcription of vadR is controlled by the VxrAB system (Fig. 1d), which has been reported 
to control cell-wall synthesis and repair, biofilm formation, type 6 secretion, and iron 
homeostasis in V. cholerae18,19,22,30. In closely related Vibrio parahaemolyticus, the VxrAB 
system (here called VbrKR) has been reported to respond to ß-lactam antibiotics via direct 
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interaction with the histidine kinase, VbrK31. Our results support activation of the system by 
ß-lactam antibiotics, i.e. penicillin G (Figs. 5a-b), however, since we also discovered vadR 
activation in the presence of A22 (Fig. S5a) it is likely that additional cues also trigger the 
system.    
  Indeed, VadR is readily detectable under standard growth conditions (Fig. 1c) 
suggesting a regulatory role for the system under non-stress conditions. Here, VadR might 
take the role of adjusting cell growth with the production of CrvA and biofilm-forming factors 
(Fig. 6d). CrvA is an abundant periplasmic protein6 and biofilm components require 
transport across two membranes to reach their final destination23. Uncoordinated export of 
proteins and polysaccharides can clog the cellular transport machineries and compromise 
the permeability barrier or structural integrity of the cell32,33. It is therefore vital for the cell to 
synchronize these functions with cell growth and sRNAs have previously been implicated 
in this process34. For example, sRNAs activated by the alternative sigma-factor E promote 
envelope homeostasis by tuning the levels of newly synthesis outer membrane proteins in 
response to misfolded proteins in the periplasm8,21,35,36. VadR could take an analogous 
position in the VxrAB stress response system and given the relatively short half-life of VadR 
(~3min, Fig. S1c), sRNA-based regulation might provide regulatory dynamics that are 
superior over canonical protein-based regulation14. This hypothesis is supported by our 
finding that VadR directly base-pairs with the mRNAs of the multiple biofilm components 
(Fig. 3a), rather than acting through a higher-level transcriptional regulator such as VpsT. 
VpsT activates the transcription of the genes encoding biofilm components in V. cholerae37 
and is repressed by the VqmR sRNA, which blocks biofilm formation20,38. Therefore, over-
expression of VadR or VqmR has similar consequences for biofilm formation in V. cholerae, 
however, the underlying molecular mechanisms differ. Deciphering these differences will 
allow important conclusions about the biological roles of these sRNAs and their associated 
pathway, but could also provide a deeper understanding of how sRNAs evolve and select 
their targets39.    
  Our data further showed that besides repressing biofilm formation and cell curvature, 
VadR also inhibits the expression of vc2352 (encoding a NupC-type nucleoside 
transporter40), irpA (encoding an iron-regulated membrane protein carrying a peptidase 
domain41), vca0864 (encoding a methyl-accepting chemotaxis protein42), and vca0075, 
which has unknown functions43 (Figs. 3a and 6d). We do not yet understand how these 
genes fit into the VadR regulon, however, vca0075 is co-repressed with cdgA20, a 
diguanylate cyclase gene with documented functions in biofilm formation44. In addition, 
Vca0864 has been reported to inhibit chemotaxis towards N-acetylglucosamine, which is a 
key component of peptidoglycan45. Simultaneous repression of biofilm formation and 
Vca0864 by VadR could promote cell motility towards N-acetylglucosamine and thereby 
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replenish the necessary building blocks for peptidoglycan remodeling under conditions of 
cell-wall stress.   
  How CrvA affects peptidoglycan remodeling in V. cholerae is currently not fully 
understood. Previous reports revealed that filament-like proteins such as CrvA and CreS 
render the activity of enzymes involved in cell-wall synthesis and thereby reduce the rate of 
peptidoglycan insertion at one site of the cell6,46. This process results in asymmetric growth 
and cell curvature, but might also create an “Achilles heel” in the presence of ß-lactam 
antibiotics or other cell-wall damaging agents. VadR-mediated repression of crvA mRNA 
could help to mitigate this effect by reducing the de-novo production of CrvA protein. 
METHODS 
Bacterial strains and growth conditions  
Bacterial strains used in this study are listed in Supplementary Table S2. Details for strain 
construction are provided in the Supplementary Material and Methods section. V. cholerae 
and E. coli cells were grown under aerobic conditions (200rpm, 37°C) in LB (Lenox). Where 
appropriate, media were supplemented with antibiotics at the following concentrations: 100 
µg / ml ampicillin; 20 µg / ml chloramphenicol; 50 µg / ml kanamycin; 50 U / ml polymyxin 
B; 5 mg / ml streptomycin, 5 µg / ml cefalexin.  
 
Plasmids and DNA oligonucleotides  
All plasmids and DNA oligonucleotides used in this study are listed in Supplementary Tables 
S3 and S4, respectively. Cloning details are provided in the Supplementary Material and 
Methods section. 
RNA isolation and Northern blot analysis  
Total RNA was prepared and blotted as described previously47. Membranes (GE Healthcare 
Amersham) were hybridized with [32P] labelled DNA oligonucleotides at 42°C. Signals were 
visualized using a Typhoon phosphorimager (GE Healthcare) and quantified using Gelquant 
software (biochemlabsolutions). 
Microscopy analysis  
Samples for microscopy analyses were prepared by growing the respective V. cholerae 
strains in LB to OD600 of 0.4. Cells were pelleted, washed in 1xPBS, and finally resuspended 
in 2.5% paraformaldehyde in 1xPBS. Phase contrast imaging was performed on a Zeiss 
Axio Imager M1 microscope equipped with EC Plan Neofluar 100x/ 1.3 Oil Ph3 objective 
(Zeiss). For additional magnification a 2.5 x optovar was used. Image acquisition was 
conducted with the AxioVision software-package (Zeiss). For further analysis, e.g. 
measurements of cell center line curvature, cell length and cell are, the FIJI-plugin MicrobeJ 
was used48,49.  
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Flow chamber biofilms and confocal imaging  
The strains were grown in LB medium supplemented with 50 μg/mL kanamycin, to mid-
exponential growth phase, before introducing into microfluidic flow chambers. Flow 
chambers were constructed from poly(dimethylsiloxane) bonded to glass coverslips using 
an oxygen plasma. The microfluidic channels measured 500 μm in width, 100 μm in height 
and 7 mm in length. After the cultures were introduced into the channels, the channels were 
incubated at 24°C for 1 h without any flow, to allow cells to attach to the bottom glass surface 
of the channels. The flow was then set to 0.3 μl/min for approximately 18 h before images 
were acquired. Cells were stained with green fluorescent nucleic acid stain dye, SYTO 9 
(Thermo Fisher Scientific), by exchanging the syringes containing LB with SYTO 9 for 30 
min. Flow rates were controlled using a high-precision syringe pump (Pico Plus, Harvard 
Apparatus). To acquire the spatiotemporal information of individual cells in a growing 
biofilm, time lapse confocal microscopy was performed as described previously50. To 
reduce photobleaching and phototoxicity during time-lapse imaging, a live feedback 
between image acquisition, image analysis and microscope control was used to 
automatically detect the biofilm height to avoid imaging of empty space on top of the 
biofilms. Images were acquired with an Olympus 100x objective with numerical aperture of 
1.35, using a Yokogawa spinning disk confocal scanner and laser excitation at 488 nm. 
Images were acquired at spatial resolution of 63 nm in the xy plane and 400 nm along the 
z direction. To detect all single cells, measure cell curvature of each cell, and quantify the 
relative vadR promoter-reporter strength from biofilm grown in flow chambers, biofilm 
images were analysed with the BiofilmQ software available from the Drescher Lab51. 
Kymograph heatmaps showing the strength of vadR promoter and cell curvature during 
biofilm growth were generated with BiofilmQ. 3-D cell rendering was done using BiofilmQ-
analysed biofilm data using the ParaView software52. Biofilm images were prepared with 
the NIS-Elements AR Analysis software (Nikon) by cropping a fixed z-plane with xy and yz 
projections. 
RNA-seq analysis  
Biological triplicates of V. cholerae ΔvadR strains harboring pBAD-Ctr or pBAD-vadR 
plasmids were grown to exponential phase (OD600 of 0.2) in LB media. sRNA expression 
was induced by addition of L-arabinose (0.2% final conc.). After 10 min of induction, cells 
were harvested by addition of 0.2 volumes of stop mix (95% ethanol, 5% (v/v) phenol) and 
snap-frozen in liquid nitrogen. Total RNA was isolated and digested with Turbo DNase 
(Thermo Fischer Scientific). Ribosomal RNA was depleted using Ribo-Zero kits (Epicentre) 
for Gram-negative bacteria, and RNA integrity was confirmed using a Bioanalyzer (Agilent). 
Directional cDNA libraries were prepared using the NEBNext Ultra II Directional RNA 
Library Prep Kit for Illumina (NEB, #E7760). The libraries were sequenced using a HiSeq 
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1500 system in single-read mode for 100 cycles. The read files in FASTQ format were 
imported into CLC Genomics Workbench v11 (Qiagen) and trimmed for quality and 3’ 
adaptors. Reads were mapped to the V. cholerae reference genome (NCBI accession 
numbers: NC_002505.1 and NC_002506.1) using the “RNA-Seq Analysis” tool with default 
parameters. Reads mapping to annotated coding sequences were counted, normalized 
(CPM) and transformed (log2). Differential expression between the conditions was tested 
using the “Empirical Analysis of DGE” command. Genes with a fold change ≥ 1.75 and an 
FDR adjusted p-value ≤ 1E-3 were defined as differentially expressed. 
Fluorescence measurements  
Fluorescence assays to measure GFP expression were performed as described 
previously26. E. coli strains expressing translational GFP-based reporter fusions were grown 
for 16h in LB medium and resuspended in 1xPBS. Fluorescence intensity was quantified 
using a Spark 10M plate reader (Tecan). V. cholerae and E. coli strains carrying mKate2 
transcriptional reporters were grown in LB medium, resuspended in 1xPBS, samples were 
collected at the indicated time points and mKate2 fluorescence was measured using a 
Spark 10M plate reader (Tecan). Control samples not expressing fluorescent proteins were 
used to subtract background fluorescence. 
Western blot analysis  
Experiments were performed as previously described47. If not stated otherwise, 0.075 OD / 
lane were separated using SDS-PAGE and transferred to PVDF membranes for Western 
blot analysis. 3xFLAG-tagged fusions were detected using anti-FLAG antibody (Sigma, 
#F1804). RnaPα served as a loading control and was detected using anti-RnaPα antibody 
(BioLegend, #WP003). Signals were visualized using a Fusion FX EDGE imager (Vilber) 
and band intensities were quantified using BIO-1D software tools (Vilber).  
ß-galactosidase reporter assays  
A plasmid library, expressing V. cholerae genomic fragments53, was screened for activation 
of vadR promotor (PvadR) activity. To this end, lacZ-deficient E. coli BW25113 strains, 
harboring pNP-122, were transformed with pZach library plasmids. Transformants were 
selected on LB plates, containing the respective antibiotics and 20 µg / ml 5-Brom-4-chlor-
3-indoxyl-β-D-galactopyranosid (X-gal). 23,000 colonies (representing ~11-fold coverage) 
were monitored for ß-galactosidase activity. Obtained hits were validated for ß-
galactosidase activity as described previously, with modifications54. Briefly, E. coli BW25113 
strains harboring the pZ genomic fragment expression plasmids and pNP-122 were grown 
to OD600 of 1.5 in LB. Cells were resuspended in Z-buffer to yield 1.0 OD600 / ml. Cells were 
lysed by addition of 75 µl chloroform and 50 µl 0.1 % SDS and vortexing. Lysates were 
centrifuged (16.000 x g, 5 min) and the resulting supernatant treated with O-Nitrophenyl-β-
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D-galactopyranoside (ONPG). The reactions were stopped by addition of sodium carbonate 
(Na2CO3). The specific activities were obtained by measuring absorbance at OD420, OD550, 
and OD600 using a Spark 10M plate reader (Tecan). ß-galactosidase activity was deduced 
from the values by calculating Miller units. 
Sequence alignments  
VadR and its promoter sequences among various Vibrio species were aligned using the 
MultAlin webtool55. Vch: Vibrio cholerae (NCBI:txid243277), Vmi: Vibrio mimicus 
(NCBI:txid1267896), Van: Vibrio anguillarum (NCBI:txid55601), Vqi: Vibrio qinghaiensis 
(NCBI:txid2025808), Vfu: Vibrio furnissii (NCBI:txid29494), Vfl: Vibrio fluvialis 
(NCBI:txid676), Vme: Vibrio mediterranei (NCBI:txid689), Vvu: Vibrio vulnificus 
(NCBI:txid672), Val: Vibrio alginolyticus (NCBI:txid663), Vpa: Vibrio parahaemolyticus 
(NCBI:txid670). 
Statistical analyses   
Statistical parameters for the respective experiment are indicated in the corresponding 
figure legends. n represents the number of biological replicates. Details for the performed 
statistical tests are provided in the supporting information. Statistical analyses of CFUs were 
performed as follows: The data were log10-transformed and tested for normality and equal 
variance using Kolmogorov–Smirnov and Brown–Forsythe tests, respectively. The data 
were tested for significant differences using one-way ANOVA and post hoc Holm-Sidak 
tests. Significance levels are reported in the in the supporting information. Statistical 
analysis was performed using SigmaPlot v14 (Systat). No blinding or randomization was 
used in the experiments. No estimation of statistical power was used before performing the 
experiments, and no data were excluded from analysis.  
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FIGURES 
Figure 1 
 
Figure 1: The VadR sRNA alters V. cholerae cell shape and is transcribed by VxrB  
(a) Centerline curvature of V. cholerae cells expressing the indicated sRNAs (x-axis). The blue line 
indicates the median, boxes represent 25th and 75th percentiles, whiskers represent 5th and 95th 
percentiles and notches indicate 95% confidence intervals for each median. n of each set is listed 
above the x-axis. (b) Alignment of vadR and its promoter sequence from various Vibrio species. The 
-35 box, -10 box, TSS (arrow) and the Rho-independent terminator (brackets) are indicated. Putative 
VxrB binding sites and binding motifs (bold) are illustrated. (c) VadR expression throughout bacterial 
growth was tracked on Northern blots. V. cholerae wild-type or vadR mutant cells carrying either a 
control plasmid (pCtr) or a constitutive vadR overexpression plasmid (pVadR) were tested. (d) V. 
cholerae ΔvxrABCDE cells were complemented with various cistrons of the vxrABCDE operon and 
tested for VadR expression on Northern blots. Expression of the vxrABCDE fragments was driven 
by the inducible pBAD promoter (0.02 % L-arabinose final conc.) and exponentially growing cells 
were harvested (OD600 of 0.2). A V. cholerae strain wild-type harboring an empty vector served as 
control. The experiment was performed with three independent biological replicates (n = 3). 
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Figure 2 
 
Figure 2: Target spectrum of VadR and its role in biofilm formation  
(a) Volcano plot analysis showing differentially regulated genes after pulse induction of VadR. Genes 
with absolute fold changes ≥ 1.75 and an FDR corrected p-value of ≤ 0.001 were considered 
significantly expressed and are indicated. (b) Genomic context of the major biofilm cluster in V. 
cholerae. (c) Gene enrichment analysis of the differentially expressed genes shown in (a) using 56. 
(d) Colony biofilm images of V. cholerae ∆hapR cells carrying the indicated plasmids. 5 µl of each 
strain were spotted on a LB agar plates and incubated for 24h at room temperature before imaging. 
(e-h) Confocal Spin Disk Microscope images of biofilms (grown for 18 h) formed by V. cholerae 
ΔhapR cells carrying the following plasmids: (e) control plasmid, (f) vadR overexpression, (g) vadR 
ΔR1 overexpression. (h) A ΔhapR/ΔrbmA mutant harboring a control plasmid was used for 
comparison. The central images show bottom-up views, and the flanking images show vertical optical 
sections. Scale bars = 10 µm. (i) Local cell density as a function of distance from the substratum was 
plotted for each of the indicated strains using the BiofilmQ software51. 
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Figure 3 
 
Figure 3: VadR is a direct inhibitor of crvA and key biofilm transcripts  
(a) Genes post-transcriptionally regulated by VadR. Fluorescence intensities of E. coli strains 
carrying the gene-specific reporters and the control plasmid (pCtr) were set to 1. Bars show mean of 
biological replicates ± SD, n = 4. (b-e) Prediction of RNA duplex formation between selected mRNAs 
and VadR. Numbers indicate the distances from the TSS for VadR and the start codons of the target 
mRNA sequences, respectively. Arrows indicate the mutations tested in (f-i). (f-i) Validation of the 
predicted mRNA-sRNA duplexes shown in (b-e) using compensatory base-pair mutations. 
Fluorescence levels of E. coli strains harboring an empty vector control (pCtr) were set to 1. Bars 
show mean of biological replicates ± SD, n = 6. 
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Figure 4 
 
Figure 4: VadR modulates V. cholerae curvature by repressing CrvA   
(a) Quantification of CrvA-3xFLAG protein levels in V. cholerae wild-type and vadR-deficient cells. 
Total protein samples of the indicated strains were harvested (OD600 of 0.5) and tested by Western 
blot analysis. CrvA-3xFLAG protein levels detected in the wild-type cells were set to 1. Bars show 
mean of biological replicates ± SD, n = 3. Statistical significance was determined using one-way 
ANOVA and post-hoc Holm-Sidak test. (b) Microscopy of cells used in (a; –Cef). A second set of 
cells was treated with cefalexin for 1h (+Cef) after reaching an OD600 of 0.5. Shown are representative 
fields of vision. Scale bars = 5 µm. (c) Analysis of cell centerline curvature in –Cef samples of (b). 
The curvature mean of wild-type cells was set to 1. A blue line indicates the median, boxes represent 
25th and 75th percentiles, whiskers represent 5th and 95th percentiles and notches indicate 95% 
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confidence intervals for each median. n of each set is listed above the x-axis. Statistical significance 
was determined using Kruskal-Wallis test and post-hoc Dunn’s test. 
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Figure 5 
 
Figure 5: VadR mediates ß-lactam resistance through repression of CrvA  
(a) V. cholerae wild-type and vxrABCDE mutant strains were grown to OD = 0.2 (pre) and split into 
two sets. One set was treated with penicillin G, while the other set received a mock treatment. After 
3h, RNA was isolated and VadR expression was monitored by Northern analysis. (b) VadR promoter 
activity was tested under the same conditions as in (a) using a fluorescent transcriptional reporter. 
Promoter activities of mock-treated strains were set to 1. Bars represent mean of biological replicates 
± SD, n = 4. (c) The indicated V. cholerae strains (x-axis) were grown to OD600 = 0.4 and treated with 
Penicillin G for 3h. Survival after treatment was determined by counting colony forming units (CFUs). 
Bars represent mean of biological replicates ± SD, n = 6. Statistical significance was determined 
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using one-way ANOVA and post-hoc Holm-Sidak test. Significantly different groups (p < 0.01) are 
labelled with corresponding letters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 3: RNA-MEDIATED CONTROL OF CELL SHAPE MODULATES ANTIBIOTIC 
RESISTANCE IN VIBRIO CHOLERAE 
39 
Figure 6 
 
Figure 6: VadR controls cell curvature during biofilm development    
(a) Relative activity of the vadR promoter during biofilm growth of V. cholerae. In each cell the 
fluorescence of mRuby2, expressed from the vadR promoter was normalized by the signal of the 
constitutive Ptac-promoter-driven sfGFP-fluorescence signal. Heatmap shows vadR promoter 
activity at both spatial (distance from surface of biofilm representing height of the biofilm) and 
temporal (time of biofilm growth) resolution. Subset of images show the cells from two time points 
and separate locations of the biofilm. These cells were rendered by ParaView51 after final 
segmentation and analysis using BiofilmQ51. The color of each cell represents the activity of the vadR 
promoter. (b) Spatio-temporal heatmap showing cell curvature of each cell for V. cholerae biofilms. 
Cell curvature was calculated as cell convexity parameter from BiofilmQ. Lower cell convexity (0.5) 
reflects highly curved cells and higher cell convexity (1) indicates straight cells. To show the cell 
curvature of individual cell inside the biofilms, similar positions of the biofilm as in (a) subset of images 
were selected for rendering. In these subsets of images, the color represents the cell curvature of 
each cell. (c) A correlation graph was plotted for vadR promoter activity as function of cell curvature. 
Calculation of vadR promoter activity and cell curvature was done for V. cholerae wild-type biofilms 
grown in flow chambers. Each point represents >1000 cells for given time point in a biofilm. The error 
bars for each point correspond to the standard error. (d) Model showing the regulatory functions of 
the VadR sRNA in V. cholerae. Expression of vadR sRNA is controlled by the VxrAB two-component 
system. The sRNA regulates multiple biological processes, including cell shape and biofilm 
formation. 
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5.1 Functional characterization of sRNAs in V. cholerae 
 
Bacteria thrive in a plethora of different habitats, due to their ability to quickly adjust to their 
surrounding environments. To this end, bacteria need to sense environmental cues and 
initiate adequate responses to rapidly adapt their gene expression profiles (122). Gene 
expression is controlled by a wide variety of transcription factors, regulating transcription 
initiation, and sRNAs, acting at the post-transcriptional level (Chapter 1.2). In S. 
typhimurium and E. coli, sRNA-mediated regulation of gene expression is wide-spread, and 
more than 100 sRNAs are expressed in these model organisms (90, 178). While initial 
screens estimated the presence of more than 500 sRNAs in V. cholerae (182), a recent 
dRNA-seq approach identified 107 putative sRNA candidates and verified the expression 
32 sRNAs (46). Despite of this abundance of post-transcriptional regulators in V. cholerae, 
only few of them have been experimentally studied (Fig. 5.1, Table 5.1).   
 
  
 
Figure 5.1: Overview of the sRNA regulatory landscape of V. cholerae: Depicted are all described sRNAs 
and experimentally validated sRNA-mRNA interactions of V. cholerae. Contributions made in the present work 
are highlighted in blue. Previously identified sRNAs and sRNA-mRNA interactions have been adapted from: 
(44, 45, 183–192, 46, 193–196, 64, 142, 144–146, 168, 169).  
 
  The present work substantially contributed to a better understanding of the sRNA 
regulatory landscape in V. cholerae (Fig. 5.1). First, we identified the MicV (formerly Vcr089) 
sRNA, as a new member of the σE-regulon in V. cholerae (Chapter 2, Appendix Table S1, 
Figs. 1, EV1). Furthermore, RNA-seq analyses combined with post-transcriptional reporter 
assays and mutational analyses, revealed that MicV controls expression of 28 genes, 
organized in 13 transcriptional units. Additionally, the present work expanded the known 
regulon of the related VrrA sRNA, by identifying 9 new mRNA targets (Chapter 2, Appendix 
Table S2, Appendix Figs. S2, Fig. 2). Second, we found that the VadR (formerly Vcr090) 
sRNA is activated by the VxrAB two-component system (Chapter 3, Figs. 1D, S1) and 
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controls the expression of 10 mRNA targets (Chapter 3, Figs. 2A, 3, S2A). Third, we 
identified 5 additional targets for the VqmR (formerly Vcr107) sRNA, including aphA, 
encoding the master regulator of low-cell density functions (Chapter 4, Table 1, Fig. 2).  
 Furthermore, the sRNA-mRNA interactions identified in this work allow us to propose 
likely mechanisms of mRNA target regulation by sRNAs in V. cholerae. Predictions of 
sRNA-mRNA duplex formation (Chapters 2-4) allows us to propose that the majority of 
sRNAs in V. cholerae base-pair to a region within -35 to +19 nucleotides from the AUG start 
codon (49 out of 58 described interactions) (Table 5.1, (50, 51, 197)). These data indicate 
that regulation of a majority of mRNA targets is achieved by ribosomal occlusion (34, 53) 
and potentially coupled degradation of sRNA-mRNA duplexes (56). In contrast to that, 
sRNA interactions within the 5’UTR, but outside the RBS window, are rare (3 out of 58 
described interactions) (Table 5.1). While base-pairing of the Qrr1-4 sRNAs within the 
5’UTR of aphA has been described to result in activation of aphA translation by an anti-
antisense mechanism (168, 169), we observed negative regulation for the MicV-btuB 
(Chapter 2, Fig. 2D) and VqmR-ndk interactions (Chapter 4, Fig. 2B). Interestingly, those 
interactions occur within a few nts of the RBS window (Table 5.1, Chapter 2, Appendix Fig. 
S3), and it would be interesting to use toeprinting analyses to test whether these interactions 
result in ribosomal occlusion (197), or if another mechanism is involved. For instance, in S. 
typhimurium the GcvB sRNA inhibits translation of the gltI mRNA, by base-pairing to a 
translational enhancer element, located -57 to -47 nts from the start codon (59). Intriguingly, 
the present work identified the first interactions of sRNAs deep within the CDS of target 
mRNAs in V. cholerae (6 out of 58 described interactions) (Table 5.1, Chapter 2, Appendix 
Fig. S3). While it is currently unclear how target regulation is achieved in those cases, the 
MicC sRNA has been reported to regulate expression of the ompD mRNA in S. typhimurium 
by base-pairing to a region deep in the CDS (+67 to +78 nts from the start codon). In this 
case, regulation of ompD is not achieved by inhibiting translation initiation, but by 
accelerating RNase E-mediated transcript decay (60). Such a mechanism would require the 
presence of RNase E-sites in the corresponding region of the transcripts, but it is currently 
unclear if RNase E-sites are associated to those transcripts. However, recent approaches 
employing TIER-seq (Transiently inactivating an endoribonuclease followed by RNA-seq), 
have successfully mapped RNAse E-sites on a transcriptome scale in S. typhimurium (198). 
It would be interesting to use a similar approach in V. cholerae to test for the presence of 
RNase E-sites , located close to the predicted base-pairing regions, and to confirm the 
predicted mechanism of target regulation.  
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Table 5.1: Overview of sRNA-mRNA interactions in V. cholerae: Depicted are validated sRNA-mRNA inter-
actions with predicted or validated base-pairing interactions. Nucleotide positions of sRNAs involved in base-
pairing are depicted with respect to the corresponding TSSs, and nucleotide positions of mRNAs are depicted 
with respect to the AUG start codons. The interaction regions have been classified with respect to the region 
occluded by the 30S ribosomal subunit: -35 - +19 nt from the AUG start codon (50, 51, 197). n.a. = not available. 
sRNA mRNA sRNA  region 
mRNA 
region classification 
seed- 
region reference 
MicV ompT 2 - 17 -7 - -22 RBS  R1 Chapter 2 
MicV vca0951 10 - 18 -5 - -13 RBS  R1 Chapter 2 
MicV rpoE 5 - 19 -41 - -29 RBS  R1 Chapter 2 
MicV vc1563 1 - 9 +48 - +58 CDS R1 Chapter 2 
MicV dsbD 1 - 10 +59 - +72 CDS R1 Chapter 2 
MicV vc1485 1 - 16 -19 - -5 RBS  R1 Chapter 2 
MicV ompA 1 - 14 +2 - +16 RBS  R1 Chapter 2 
MicV bamD 1 - 18 -3 - +10 RBS  R1 Chapter 2 
MicV prvT 1 - 9 -11 - -1 RBS  R1 Chapter 2 
MicV btuB 1 - 8 -47 - -34 5'UTR R1 Chapter 2 
MicV ushA 1 - 10 -34 - -19 RBS R1 Chapter 2 
MicV ompU 1 - 8 +67 - +73 CDS R1 Chapter 2 
MicV oppA 1 - 9 +48 - +55 CDS R1 Chapter 2 
MicX vc0620 259 - 293 -18 - +4 RBS n.a. (192) 
MtlS mtlA 1 - 70 -75 - -5 RBS n.a. (44, 45) 
Qrr1-4 hapR diff. in Qrr1-4 -35 - -5 RBS n.a. (64) 
Qrr1-4 aphA diff. in Qrr1-4 -147 - -120 5‘UTR n.a. (168, 169) 
Qrr1-4 luxO diff. in Qrr1-4 -23 - -3 RBS n.a. (169) 
Qrr1-4 vc0939 diff. in Qrr1-4 -23 - 38 RBS n.a. (185) 
TarA ptsG 9 - 28 -3- +24 RBS n.a. (187) 
TarB tcpF 12 - 43 -22 - +8 RBS n.a. (188) 
TfoR tfoX 2 - 59 -51 - -2 RBS n.a. (189–191) 
VadR vpsU 18 - 26 -10 - -2 RBS R2 Chapter 3 
VadR rbmA 4 - 18 -32 - -18 RBS R1 Chapter 3 
VadR rbmD 1 - 23 -33 - -15 RBS R1 Chapter 3 
VadR vpsL 16 - 29 -22 - -2 RBS R1 Chapter 3 
VadR crvA 1 - 19 -25 - -2 RBS R1 Chapter 3 
VadR vca0864 1 - 15 -11 - +13 RBS R1 Chapter 3 
VadR irpA 1 - 21 -10 - +18 RBS R1 Chapter 3 
VadR vc2352 24 - 36 -1 - +14 RBS R2 Chapter 3 
VadR vca0075 15 - 25 -24 - -13 RBS R1 Chapter 3 
VqmR vca0068 76 - 91 -15 - +3 RBS R2 (46) 
VqmR vc0200 76 - 91 -16 - +3 RBS R2 (46) 
VqmR vc1063 54 - 67 -14 - +5 RBS R1 (46) 
VqmR vpsT 74 - 99 -22 - +5 RBS R2 (46) 
VqmR vc1865 93 - 113 -9 - +11 RBS R2 (46) 
VqmR vc1449 75 - 95 -24 - +3 RBS R1 (46) 
VqmR vca0917 84 - 99 -17 - -8 RBS R2 (46) 
VqmR vca0591 76 - 90 -11 - +3 RBS R2 (46) 
VqmR ulaA 93 - 104 +8 - +20 RBS R2 Chapter 4 
VqmR vc0865 80 - 102 -27 - -2 RBS R2 Chapter 4 
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sRNA mRNA sRNA  region 
mRNA 
region classification 
seed- 
region reference 
VqmR ndk 62 - 72 -57 - -33 5'UTR R1 Chapter 4 
VqmR vc0789 58 - 71 -19 - -2 RBS R1 Chapter 4 
VqmR aphA 131 - 143 -13 - -1 RBS R3 Chapter 4 
VrrA ompT 69 - 83 -21 - -2 RBS R1 Chapter 2, (144) 
VrrA vca0951 57 - 83 -11 - +13 RBS R1 Chapter 2 
VrrA rpoE 71 - 80 -38 - -23 RBS R1 Chapter 2 
VrrA vc1563 64 - 75 +48 - +57 CDS R1 Chapter 2 
VrrA dsbD 61 - 72 +60 - +72 CDS R1 Chapter 2 
VrrA vc1485 69 - 82 -19 - -5 RBS R1 Chapter 2 
VrrA ompA 64 - 86 -14 - +21 RBS R1 Chapter 2, (142) 
VrrA bamD 72 - 79 +3 - +10 RBS R1 Chapter 2 
VrrA pal 93 - 102 -11 - -2 RBS R2 Chapter 2 
VrrA lpp 90 - 107 -21 - -5 RBS R2 Chapter 2 
VrrA acfA 91 - 106 -25 - -6 RBS R2 Chapter 2 
VrrA tcpA 70 - 106 -25 - +19 RBS R2 (142) 
VrrA rbmC 91- 106 -25 - -8 RBS R2 (146) 
VrrA vrp 72 - 84 -15 - -3 RBS R1 (145) 
 
 
5.2 Bacterial stress response systems are a hotspot for sRNA-
mediated regulation 
 
5.2.1 The MicV and VrrA sRNAs act as the non-coding arm of the σE-stress 
response in V. cholerae 
 
An interesting feature of sRNAs are their dynamic expression profiles, observed even during 
batch culture conditions in the laboratory. In many cases, sRNA expression profiles 
correlated with corresponding binding to the RNA-Chaperone Hfq (90). Intriguingly, in E. 
coli a majority of sRNAs have been described to show highest expression levels in 
stationary phase of bacterial growth (100, 103), and Hfq levels have been reported to 
increase by two-fold under stationary phase conditions (199). Entry into stationary phase 
growth conditions presents a drastic change in environmental conditions, for instance due 
to nutrient limitation and accumulation of metabolic waste products. Consequently, 
adaptation to stationary phase growth conditions includes the activation of several stress 
response systems and changes in gene expression to embark on strategies for persistence 
in harsh environments (155). Interestingly, the induction of sRNA expression in stationary 
phase correlates with the observed changes in gene expression, indicating the potential 
activation of sRNA expression by alternative sigma factors or stress response systems 
(100). Similar observations have been made in V. cholerae. For instance, Papenfort et al. 
probed the expression patterns of putative sRNAs and found increased expression levels 
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in stationary phase for 23 out of 32 sRNAs (46).  
 Intriguingly, the MicV and VrrA sRNAs have been reported to be expressed 
specifically in stationary phase of bacterial growth (46, 142), which was confirmed in the 
present study (Chapter 2, Fig. EV1). Additionally, the present study provides evidence that 
the micV and vrrA promoters are strongly activated in stationary phase (Chapter to, Figs. 1, 
EV1). Entry into stationary phase of bacterial growth has been reported previously as an 
inducing condition to activate the σE-stress response (200), and indeed the present work 
showed direct activation of both sRNA promoters by the alternative sigma factor σE (Chapter 
2, Appendix Table S1, Figs. 1, EV1). Furthermore, the micV promoter responded 
dynamically to ectopic rpoE overexpression (Chapter 2, Fig. EV1F). Together, these data 
suggested high expression levels of both sRNAs under σE-inducing conditions. Similar 
observations have been made for the σE-dependent promoters of E. coli. Mutalik et al., 
performed genome wide, in vivo analyses of σE-dependent promoters in E. coli and found 
that the promoters driving expression of the σE-dependent sRNAs RybB and MicA are 
ranked among the strongest in the σE-regulon (201). Consequently, the conservation of σE-
dependent sRNAs in Enterobacteria (141) (Chapter 2, Fig. 1A, Fig. EV1A), and high 
expression levels during envelope stress conditions point to a crucial role in the σE-regulon. 
Indeed, the present study showed reduced cell survival of V. cholerae under envelope 
stress conditions in absence of σE-dependent sRNAs (Chapter 2, Fig. 1F) and increased 
survival of strains lacking rpoE and overexpressing the σE-dependent sRNAs (Chapter 2, 
Fig. 4C). Increased protection from lysis during σE shutoff was also previously reported for 
the RybB and MicA sRNAs (140).   
  The important role of σE-dependent sRNA during envelope stress became evident 
by analyses of their respective target profiles. The σE stress response is activated by 
accumulation of misfolded OMPs, and misfolded OMPs in the periplasm have been reported 
to insert into the inner membrane, disrupt the proton motif force and potentially cause cell 
death (127). Rapid downregulation of stable omp mRNAs upon σE-activation presents an 
obvious solution to restore envelope homeostasis and has been previously observed in E. 
coli (137). However, sigma factors are restricted to act as transcriptional activators (28). An 
elegant solution to this problem would be to employ post-transcriptional regulators as 
indirect, negative regulators in the regulon (140, 202). Indeed, the RybB and MicA sRNAs 
have been identified to be the responsible for downregulating the expression of all major 
OMPs in E. coli, and related enterobacteria (115, 140, 141). For instance, the half-life of the 
ompA mRNA has been reported to be ~15 min (203), and is reduced to ~5 min upon rpoE 
induction (137), or ~3 min after pulse-induction of rybB (115). In the present work, we made 
similar observations and could show that ompT, ushA, and lpp mRNA levels are rapidly 
reduced after pulse-induction of rpoE. Importantly, the observed reduction of mRNA half-
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life was dependent on the presence of the VrrA and MicV sRNAs (Chapter 2, Fig. 3G-I). 
 The mRNA target profiles of MicA and RybB have been reported to include all major 
OMPs and several other transcripts of E. coli, and related enterobacteria (115, 140). In 
addition to that, the σE-dependent sRNA MicL has been reported to control expression of 
lpp (139). Furthermore, it has been reported that RybB controls expression of 16 mRNA 
targets, MicA controls expression of 9 mRNA targets, and 6 mRNA targets, including ompA 
and lamB, have been reported to be regulated by both sRNAs (140) (Fig. 5.2). Similar to 
the observed targets of RybB and MicA, we found that the mRNA targets of the MicV and 
VrrA sRNAs in V. cholerae include all major OMPs and the rpoE-rseABC operon (Chapter 
2. Fig. 2, Appendix Table S2, Appendix Fig. S2). Interestingly, previous studies found 
increased mRNA levels of the rpoE-rseABC operon in V. cholerae hfq mutants (68) and a 
RIL-seq approach in E. coli suggested that the MicL sRNA base-pairs to rpoE-rseABC 
mRNA (120), indicating that autorepression of the rpoE operon by sRNAs could be a 
conserved feature to further modulate the envelope stress in many bacteria. Intriguingly, 
the strongest promoter in the σE-regulon of E. coli has been reported to be the one driving 
expression of rpoE (201), and we identified a σE-motif in the promoter of rpoE in V. cholerae 
(Chapter 2, Appendix Table S1). Autorepression of their associated transcription factor by 
sRNAs has been reported before (202), and in this case might create an important 
feedback-circuit in which the MicV and VrrA sRNAs can modulate their own expression and 
the output of the σE-stress response. In agreement with this hypothesis, we found increased 
σE-activity in cells lacking the MicV and VrrA sRNAs (Chapter 2, Appendix Fig. S1C). 
Furthermore, we found that MicV and VrrA down-regulate expression of the bamD gene 
(Chapter 2, Fig. 2). BamD is part of the BAM (ß-barrel assembly machinery) complex, that 
has been reported to be responsible for integrating OMPs into the outer membrane (204). 
In E. coli, bamD is encoded by the yfiO gene and depletion of YfiO has been shown to 
reduce OMP levels (205). Thus, the regulation of BamD synthesis by MicV and VrrA, 
suggests the presence of another mechanism to relieve envelope stress, by reducing the 
amount of OMPs that get transported to the outer membrane under envelope stress 
conditions.  
 In contrast to RybB and MicA, we found that the majority of mRNA targets are co-
regulated by both MicV and VrrA (Fig. 5.2). We identified 5 unique mRNA targets for MicV, 
3 unique mRNA targets for VrrA, and 8 transcription units containing 23 genes for both 
sRNAs, suggesting functional redundancy for the regulation of most targets (Chapter 2, Fig. 
2, Appendix Fig. S2).  
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Figure 5.2: Comparison of the non-coding arms of the σE-response of E. coli and V. cholerae: In E. coli, 
σE activates the expression of ~100 mRNAs, the three sRNAs RybB, MicA, and MicL, as well as its own 
expression. RybB and MicA control expression of 31 mRNAs, and collectively regulate the expression 6 mRNAs. 
MicL controls expression of a single target, lpp, and might regulate expression of the rpoE-rseABC operon. In 
V. cholerae, the present work predicted σE to activate the expression of ~73 mRNAs, the MicV and VrrA sRNAs, 
as well as its own expression. MicV and VrrA control expression of 31 genes, however the majority of mRNAs 
are jointly regulated by both sRNAs. Both, MicV and VrrA, directly control expression of the rpoE-rseABC 
operon. The data for E. coli has been obtained from: (120, 140) and the data for V. cholerae from Chapter 2, 
respectively.  
5.2.2 On the role of sRNA redundancy  
 
Functional redundancy, i.e. co-regulation of the expression of a single mRNA by multiple 
sRNAs, has been observed in numerous studies (180). Recent studies have probed global 
sRNA-target interactions using RIL-seq and found several mRNAs to interact with multiple 
sRNAs (120). The most prominent example is presented in the regulation of OMPs by 
multiple sRNAs (141). For instance, the ompA mRNA has been reported to interact with the 
MicA (73, 115, 138), RybB (115, 140), and RseX (206) sRNAs in E. coli. In the present 
study we found that the MicV and VrrA sRNAs jointly control expression of 8 transcriptional 
units, encoding several OMPs (Chapter 2, Fig. 2, Appendix Fig. S2, Appendix Table S2). 
Interestingly, we observed differences in the potency of regulation of several targets by 
either MicV or VrrA. For instance, MicV appeared to be a stronger repressor of ompT and 
rpoE, while VrrA repressed ompA and bamD more efficiently (Chapter 2, Fig. 2C, Appendix 
Table S2). A likely explanation for this observation might be differences in sRNA stability 
(Chapter 2, Fig. EV1D) or different strength of regulation due to energetically more or less 
favorable base-pairing to the corresponding target (Chapter 2, Appendix Fig. S3).   
 The reason for the regulation of OMPs by multiple sRNAs is unclear, but it might be 
important to achieve saturated regulation for very abundant mRNAs (207). Indeed, omp 
mRNAs have been reported to be very stable and highly abundant (203). In line with this 
observation, we found increased ompT mRNA (N. Peschek, unpublished results) and 
increased OmpT protein levels under stationary phase growth conditions, when compared 
to exponential phase growth conditions (Chapter 2, Appendix Fig. S2B). Thus, the 
regulation by multiple sRNAs might be required to achieve rapid shut-off of translation under 
envelope stress conditions. Interestingly, we observed no difference in the decay of the 
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ompT mRNA after rpoE pulse induction in absence of micV or vrrA alone. However, the 
decay was attenuated if both sRNAs were absent (Chapter 2, Fig. 3G). Similar to that, we 
found a maximal increase of OmpT protein levels in micV, vrrA double mutants (Chapter 2, 
Appendix Fig. S1B). Curiously, vrrA mutation did not result in changed OmpT protein levels 
(Chapter 2, Appendix Fig. S1B), and differences in σE activity, while the micV, vrrA double 
mutants displayed increased σE activity (Chapter 2, Appendix Fig. S1C). In contrast to that, 
we found that only vrrA or vrrA, micV double mutants showed increased survival upon 
induction of envelope stress by exposure to ethanol (Chapter 2, Fig. 1F). Together these 
data suggest, that MicV and VrrA serve specialized functions in the envelope stress 
response, i.e. VrrA mediates resistance to ethanol stress conditions, and MicV is the more 
important regulator under stationary phase growth conditions.   
 A likely explanation for the observed co-regulation of multiple mRNA targets by MicV 
and VrrA is the presence of a conserved seed-region in both sRNAs (Chapter 2, Fig. 4A). 
Indeed, mutation of this conserved seed-region resulted in a loss of ompT regulation 
(Chapter 2, Figs. 3A, 3D), and base-pairing predictions of co-regulated targets with both 
sRNAs suggested energetically favorable base-pairing to occur with this seed-region 
(Chapter 2, Appendix Fig. S3). In the same line of thought, base-pairing of MicV to its unique 
targets involves the 2 nucleotides at the very 5’end, that are not conserved in the vrrA 
sequence (Chapter 2, Figs. 1A, 2A, 3D, E, 4A, Appendix Fig. S3). Indeed, seed-regions 
have been reported to mediate very selective base-pairing. For instance, the SgrS sRNA in 
S. typhimurium has been reported to discriminate between the sopD and the horizontally 
acquired sopD2 mRNA through a single nucleotide (208). Likewise, VrrA unique targets are 
regulated by a second seed-region, that is not present in MicV (Chapter 2, Figs. EV2A, 3C, 
F, Appendix Fig. S3). Intriguingly, the shared seed-region is also conserved in the functional 
homologous sRNA RybB of E. coli and related bacteria (Chapter 2, Fig. 4A). Furthermore, 
RybB functionally repressed OmpT protein synthesis in V. cholerae (Chapter 2, Fig. 4B), 
vice versa MicV and VrrA reduced OmpC and OmpA levels in E. coli (Chapter 2, Fig. 4C), 
and overexpression of each sRNAs recovered cell survival of rpoE deficient V. cholerae 
after ethanol treatment (Chapter 2, Fig. 4D). Together, these data suggest that multiple 
functionally analogous, σE-dependent sRNAs carry conserved seed-regions to mediate 
OMP repression and mitigate envelope stress in many bacteria.  
  The present work therefore has important implications for the “core sRNA” concept. 
“Core sRNAs” are largely conserved in many Enterobacteria and perform similar functions 
(209). While the overall sequences of the σE-dependent sRNAs of E. coli and V. cholerae 
are not conserved, we provide evidence that they can functionally classified by their 
conserved seed sequences and physiological analogous function.   
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5.2.3 Implications for sRNA evolution 
 
The present work addresses several questions related to how sRNAs evolve in the context 
of enterobacterial stress responses. Expression of the MicV and VrrA sRNAs is activated 
by the same sigma factor, and both sRNAs regulate OMP expression (Chapter 2, Figs. 1, 
2). These features are conserved with the functionally analogous σE-dependent sRNAs of 
E. coli (115, 140). However, albeit the highly conserved seed-region, we observed limited 
sequence homology between those sRNAs (Fig. 5.3). Furthermore, sRNAs sizes differ 
between rybB, micA, micL, vrrA, and micV. Additionally, the chromosomal locations of these 
sRNAs are not conserved between E. coli and V. cholerae. The micV gene is located in the 
intergenic region of vc2640 (encoding a hypothetical protein) and vc2641 (encoding 
argininosuccinate lyase) (Chapter 2, Fig. EV1A) and the vrrA gene is located in the 
intergenic region of vc1741 (encoding a putative TetR family transcriptional regulator) and 
vc1743 (encoding a hypothetical protein) (142). In E. coli, the rybB gene is located in the 
intergenic region of rcdA (encoding a TetR family transcriptional regulator, ~20% amino acid 
identity to vc1741) and ybjL (encoding a putative transport protein), the micA gene is located 
in the intergenic region of luxS (encoding a S-ribosylhomocysteine lyase) and gshA 
(encoding a glutamate-cysteine ligase), and the micL gene is located at the 3’ end of the of 
the cutC gene (139), but no sRNA transcription has been associated with the V. cholerae 
cutC homolog, vc0730 (46). Remarkably, the OMP composition of V. cholerae and E. coli 
is also different. In E. coli the most abundant OMPs are OmpC and OmpF (210), while in V. 
cholerae OmpT and OmpU are most abundant (211). Despite limited sequence identity 
(<20%), OmpU/T and OmpF/C have been reported to be functional analogs (212) and are 
regulated by the functional analogous sRNAs RybB, MicA (140) and MicV, VrrA (Chapter 
2, Fig. 2(142)). It is interesting to speculate whether the σE-dependent sRNAs of E. coli and 
V. cholerae present an example of convergent evolution or derived from a common ancestor 
sRNA.  
 
Figure 5.3: Overview of the functionally analogous σE-dependent sRNAs of E. coli and V. cholerae: 
Comparison of genomic location and size of the rybB, micA, micL, micV, and vrrA sRNAs (left side) as well as 
sequence identity scores (right side). 
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Importantly, the present work provides further evidence on how σE-dependent sRNAs base-
pairing to target mRNAs evolves in the framework of the envelope stress response. To 
address this, we employed E. coli RybB as a scaffold and randomized the nucleotide 
sequence of the first nine nucleotides (Chapter 2, Fig. 5A). Deletion of the first nine 
nucleotides in rybB has been reported previously to abolish regulation of all target omp 
mRNAs (49), and also prevented recovery under ethanol stress conditions in V. cholerae 
(Chapter 2, Fig. EV4D). Our laboratory selection experiments revealed successful 
enrichment of variants, that mediated ethanol resistance (Chapter 2, Fig. 4). Sequence 
analyses of the 15 most abundant variants revealed an enrichment of GC-rich sequences 
in the seed regions (Chapter 2, Figs. EV5A, B), which might be required to mediate specific 
base-pairing (213). Furthermore, we found that the conserved seed-pairing motif of σE-
dependent sRNAs was recovered in high numbers after consecutive rounds of ethanol 
treatment (Chapter 2, Fig. 5, Figs EV4, EV5A). Curiously, several other sequence variants 
were also recovered, and sufficiently mediated ethanol resistance (Chapter 2, Figs. EV4, 
EV5A, B). Base-pairing to multiple mRNA targets is thought to constrain sRNA evolution 
(161), and in line with this thought, we expected selection for fewer motifs to accommodate 
the regulatory capacity for regulation of multiple omp mRNAs in the limited size of the seed-
region. On the other hand, regulation of a single mRNA target could be established by base-
pairing to different sites in the target and thus result in an increased number of successful 
motifs (Chapter 1.2.1). Interestingly, we found that the 15 most abundant sequence variants 
all mediated resistance to ethanol treatment by downregulation of a single mRNA - ompA 
(Chapter 2, Fig. 6, Fig. EV5). Furthermore, the 15 variants showed preferential base-pairing 
to a single stranded region, involving mainly the first six codons, of ompA (Chapter 2, Fig. 
EV5). Intriguingly, we showed that the same region is targeted by the MicV and VrrA sRNAs 
(Chapter 2, Fig. EV5C, Appendix Fig. S3 (142)). In general, this matches with the 
observation that sRNA preferentially interact within a window of -35 to +19 nucleotides, with 
respect to the AUG start codon, in the target mRNA to interfere with 30S ribosome binding 
(50, 51, 197). Since the ompA leader sequence is mostly AU-rich, sRNA-pairing to the more 
GC-rich coding sequence might have resulted in more robust base-pairing and preferential 
binding to this region (Chapter 2, Fig. EV5C). Together, these data provide further evidence 
that evolution of sRNA-mRNA target pairs is dynamic and dependent on the availability of 
suitable base-pairing regions in target mRNAs.  
 Intriguingly, while all misfolded OMPs can induce the σE-stress response, specific 
OMPs have been reported to play specialized roles in mediating resistance to different 
compounds, or vary in strength of induction of the σE-stress response (131, 214). For 
instance, deletion of ompU has been reported to suppress the essentiality of σE in V. 
cholerae by an unknown mechanism (215). Furthermore, OmpU has been reported to 
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protect V. cholerae from bile salts, i.e. deoxycholate, encountered during colonization of the 
intestine (216–218). A likely explanation for this observation is that OmpU has an inhibitory 
effect on OmpT, and OmpT likely functions as channel for deoxycholate (212). In the 
present work, we found that regulation of a single OMP - OmpA - was sufficient to mediate 
resistance to ethanol stress conditions (Chapter 2, Fig. 6, Fig. EV5). Intriguingly, Zhang et 
al. performed analyses of the outer membrane proteome of E. coli cells treated with low 
amounts of ethanol (~3%), and found that deletion of ompA resulted in reduced intracellular 
ethanol levels, suggesting that OmpA is a channel for the uptake of ethanol (219). Our 
results support this hypothesis and the function of OmpA as a channel for ethanol might 
well explain the protective effect of the synthetic RybB variants under ethanol stress 
(Chapter 2, Figs. 5B, 6, Fig. EV5C-E). It is interesting to speculate what sequence variants 
and mRNA targets might be selected for under stress conditions induced with different 
compounds, i.e. deoxycholate, combinations of compounds, or in infection models and to 
test if the necessary regulation of multiple targets would lock a specific seed-region. 
5.2.5 The VadR sRNA controls cell shape and biofilm formation in response 
to cell wall damage 
 
In addition to the above-mentioned alternative sigma factors, bacteria frequently employ 
two-component systems (TCS) to respond to specific environmental stressors. These 
regulatory systems consist of a sensor histidine kinase and a cognate response regulator 
(220). Binding of a specific signal by the sensor kinase induces phosphorylation of the 
response regulator, which can activate or repress transcription of associated promoters to 
mediate adaptation (220). V. cholerae is predicted to encode 43 sensor histidine kinases 
and 52 response regulators (159) to monitor the environment for a diversity of signals (221). 
One of these systems was recently studied in detail and is referred to as VxrAB (159) (a.k.a 
WigKR (158)). The VxrAB two component system is specific to Vibrios and has been 
reported to respond to treatment with ß-lactam antibiotics, such as penicillins, and to control 
various processes, including biofilm formation, type VI secretion, virulence, peptidoglycan 
synthesis, and iron transport (158–160, 222). The related bacterium Vibrio 
parahaemolyticus encodes a vxrAB homolog called vbrKR, and Li et al. showed direct and 
specific sensing of ß-lactam antibiotics by the VbrK sensor kinase in vitro (223). However, 
it is unclear where in their life-cycle Vibrios might encounter ß-lactam antibiotics, since those 
are predominantly associated to soil-inhabiting microorganisms (224).   
 In the present work we found that the VxrAB system activates the expression of the 
VadR sRNA (Chapter 3, Figs. 1D, S1). In agreement with previous reports (158), we 
validated that vadR expression is induced by treatment with the ß-lactam antibiotic penicillin 
G, in a process that is dependent on the presence of vxrAB (Chapter 3, Figs. 5A, B). 
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However, in contrast to the hypothesis of direct ß-lactam binding by VxrA in V. cholerae, we 
found that treatment with the MreB-inhibitor A-22 also induced vadR expression, albeit to a 
smaller extent when compared to penicillin G (Chapter 3, Fig. S5A). MreB polymers have 
been reported to form cytoskeletal filaments, that, with the help of linker proteins, direct cell 
wall synthesis enzymes to insert new peptidoglycan into the cell wall (225). Both, A-22 and 
penicillin G, have been reported to damage the bacterial cell wall, resulting in a drastic loss 
of cell shape (157, 226, 227). Furthermore, we found that vadR expression is not detectable 
in vxrAB deficient cells, indicating that vadR expression is solely controlled by VxrAB 
(Chapter 3, Fig. 1D). Moreover, vadR expression was detectable at all stages of V. cholerae 
cell growth (Chapter 3, Fig. 1C), indicating that the VxrAB system is active in absence of 
cell wall damaging antibiotics. Together, these data argue against the idea that the VxrAB 
TCS is a direct ß-lactam sensor in V. cholerae. As of now, it is unclear what the exact signal 
activating the sensor kinase VxrA in V. cholerae is, but, for instance, sensing of cell wall 
intermediates upon induction of cell wall damage has been reported for other systems (228). 
 A possible answer to the question which specific signal activates VxrA in V. cholerae 
may be found in the genomic neighborhood of the vxrAB genes. The vxrAB genes are 
transcribed as a part of the operon vxrABCDE (159). Interestingly, we observed that 
overexpression of vxrABC leads to increased vadR expression, compared to vxrAB 
overexpression (Chapter 3, Fig. 1D). Furthermore, we found that expression of genomic 
fragments containing vxrABC showed increased induction of the PvadR promoter, 
compared to fragments containing only vxrAB (Chapter 3, Fig. S1E and unpublished data). 
Together, these data suggest a yet unknown regulatory role of vxrC. However, the proteins 
encoded by the vxrCDE genes are uncharacterized and feature no described protein 
domains or characterized homologs outside the Vibrio genus.   
 Intriguingly, we observed that vadR expression is highest in exponential growth 
phase (Chapter 3, Fig. 1C), indicating a potential physiological role of VadR under low cell 
density conditions. At low cell density, the master regulator AphA is active and induces 
virulence gene expression and biofilm formation (Chapter 1.4). AphA has been reported to 
directly activate expression of the biofilm regulator VpsT (229). Subsequently, VpsT 
activates expression of the gene cluster vc0916-vc0939 required for synthesis of the vibrio-
polysaccharide (VPS) and encoding the biofilm regulatory proteins rbmA-F (230). Global 
transcriptome analyses to identify mRNA targets found that VadR downregulates 
expression of all genes, except rbmB, encoded by the vc0916-vc0939 gene cluster (Chapter 
3, Figs. 2A, 3, S2). Consequently, VadR overexpression resulted in reduced biofilm 
formation (Chapter 3, Figs. 2D-I). Importantly, VadR is not the first sRNA reported to control 
biofilm formation in V. cholerae. The VqmR sRNA has been reported to control biofilm 
formation by regulating expression of the upstream regulators vpsT (46, 174) and aphA 
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(Chapter 4). However, vqmR expression is controlled by a quorum sensing system, and 
therefore activated at HCD, in the presence of increased autoinducer concentrations (46, 
174), indicating that regulation of biofilm formation by both sRNAs might not occur at the 
same time. Furthermore, it is not clear why regulation of the upstream regulators is preferred 
by VqmR, while VadR regulates the vc0916-vc0939 gene cluster directly. A potential 
explanation might be that direct downregulation of biofilm synthesis genes is faster and 
might be required to avoid initiation of biofilm formation under cell wall damaging conditions. 
Initiation of biofilm formation comes at a high metabolic cost (231), and depends on the 
secretion of VPS, RbmA, BapI, and RbmC (232), which we identified as targets of the VadR  
sRNA (Chapter 3, Figs. 2A, 3, S2). Furthermore, we found that vadR is specifically 
expressed in early phases of biofilm formation (Chapter 3, Fig. 6). Taken together, we could 
imagine a model, in which the VxrAB system monitors the cell wall status and activates 
vadR expression to prevent initiation of biofilm formation under unfavorable conditions.   
 Interestingly, we identified the crvA mRNA as another key target of the VadR sRNA 
(Chapter 3, Figs. 2A, 3, 4, S2). CrvA filaments have been reported to assemble in the 
periplasm, and asymmetrically pattern peptidoglycan insertion, thereby determining the 
curved shape of Vibrio cells (233). In the present work, we confirmed that cell curvature 
strongly correlated with CrvA levels (Chapter 3, Fig. 4). Furthermore, regulation of crvA 
expression by the VadR sRNA directly correlated with differences in cell curvature (Chapter 
3, Fig. 4). CrvA has been reported to mediate insertion of more newly synthesized 
peptidoglycan to the outer face of the curved cell, thus achieving asymmetry (233). We 
speculated that this might create a weak spot, since one side of the cell might sustain 
prolonged damage by treatment with cell wall damaging antibiotics. In agreement with this 
hypothesis, we found that increased CrvA levels resulted in reduced survival after penicillin 
G treatment (Chapter 3, Fig. S5B). Furthermore, penicillin G treatment of vadR deficient 
cells, featuring increased cell curvature, resulted in reduced cell survival, while penicillin G 
treatment of strains over-expressing vadR, featuring decreased cell curvature, resulted in 
increased survival (Chapter 3, Fig. 5C). Further analyses revealed that this phenotype was 
specifically mediated by base-pairing of VadR to crvA mRNA (Chapter 3, Fig. 5C, S5C, D). 
Together these data suggest, that vadR expression is specifically activated in response to 
cell wall damage and mediates antibiotic resistance by interfering with expression of the 
periskeletal curvature determinant CrvA. The role of sRNAs in mediating antibiotic 
resistance has only been recently appreciated (234). For instance, in S. typhimurium 
expression of the sRNA SroA is activated in response to the antibiotic tigecycline, and 
deletion of sroA resulted in increased susceptibility, while overexpression rescued this 
phenotype, however the mechanism remains elusive (235).  
 It is interesting to consider why an sRNA is used in the VxrAB stress response to 
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control biofilm formation and cell shape in response to cell wall damage. The argument that 
VxrAB could exploit VadR as an indirect negative regulator, as shown for σE-dependent 
sRNAs (139, 202) offers an insufficient explanation, since VxrAB has been reported to act 
both as an activator and repressor of transcription (222). However, since we observed that 
VadR has a short half-life of 3min (Chapter 3, Fig. S1C) and achieved fast regulation of a 
pre-existing mRNA pool (Chapter 3, Figs. 2A, S2A), direct regulation by the VadR sRNA 
instead of negative regulation by VxrAB might provide improved dynamics to the system 
(202).  
  It is also intriguing to consider what physiological role VadR might play during V. 
cholerae infections. In the intestine, V. cholerae encounters antimicrobial peptides (AMPs) 
(122), which have been reported to induce cell wall damage (236). Here, we found that cell 
wall damage induces vadR expression, through VxrAB (Chapter 3, Fig. 5A, B). Indeed, 
previous reports found that vxrB mutants displayed colonization defects (159), suggesting 
that VxrAB is active and required during host colonization. Biofilm formation plays a critical 
role in V. cholerae infections (237) and we found that VadR down-regulates expression of 
all components required for the synthesis of the biofilm matrix, including VPS (Chapter 3, 
Figs. 2A-C, 3). VPS has been reported to bind mucins, as present as a protective coat of 
epithelial cells in the intestine, and overexpression of vps has been associated with reduced 
colonization, likely due to limited migration through mucus (238). Furthermore, cell 
curvature is thought to be required for motility in dense hydrogels, as present in the mucus 
layer (233) and we found that curvature is controlled by VadR (Chapter 3, Fig. 4). The VadR 
sRNA might play an important role in controlling these processes, which should be 
addressed in future studies. Although several studies suggest V. cholerae to form biofilms 
in the well-established infant mouse and infant rabbit infection models, the composition and 
architecture of biofilms formed in vivo remains unclear (230, 237, 239). Recently, adherence 
of V. cholerae to epithelial cells has been established in vitro and was shown to strongly 
induce biofilm formation (240), which might provide an initial model system to examine the 
role of VadR in biofilm formation in conditions mimicking the in vivo situation. 
5.3 The role of sRNAs in quorum sensing of V. cholerae 
 
Bacteria frequently employ quorum sensing to control gene expression profiles and 
synchronize group behaviors, including virulence factor production and biofilm formation 
(163). An important attribute of quorum sensing controlled systems is a rapid switch - rather 
than a progressive change - of gene expression profiles, if a certain threshold of autoinducer 
molecules is detected. In many cases this switch intimately involves post-transcriptional 
regulation by sRNAs (178). For example, the QS system in Staphylococcus aureus relies 
on the RNAIII sRNA to inhibit translation of the rot mRNA, encoding a transcriptional 
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repressor of toxin production, and therefore contributes to mediate a switch between virulent 
and avirulent physiological states (178, 241). In V. cholerae, the four homologous sRNAs 
Qrr1-4 have been reported to create an ultrasensitive switch, controlling the transition from 
LCD to HCD behaviors, by controlling expression of the LCD and HCD master regulators 
AphA and HapR, respectively (64, 242). This switch between physiological states and the 
overall output of the QS response depends on the fate of RNA-duplexes, formed between 
the Qrr1-4 sRNAs and their QS-related targets (186). For instance, base-pairing of the Qrr3 
sRNA with the aphA leader has been reported to result in turnover of Qrr3, thereby forming 
a negative feedback loop to prevent overexpression of aphA, when the Qrr3:aphA ratio is 
low (186). Furthermore, while qrr1-4 expression is activated by phosphorylated LuxO, HapR 
has been reported to additionally activate the expression of qrr1-4, thus establishing a 
feedback loop to accelerate the switch from HCD to LCD mode (243). Post-transcriptional 
control of quorum sensing in V. cholerae is further expanded by the involvement of the 
CsrA/B system, in which the three redundant sRNAs CsrBCD and the regulatory protein 
CsrA control Qrr1-4 expression through LuxO (183). Additionally, V. cholerae features a 
third quorum sensing system, that depends on the autoinducer DPO. DPO binds to the 
VqmA protein and activates expression of the VqmR sRNA (46, 174).   
 Quorum sensing in V. cholerae seems to preferentially rely on post-transcriptional 
regulators instead of transcription factors, but it is currently unclear why this is the case. A 
possible explanation might be that sRNAs have been reported to achieve faster regulation, 
when compared to transcription factors (244). Indeed, we found that VqmR significantly 
reduced the mRNA levels of its targets within 15 min of pulse-induction (Chapter 4, Table 
S1, Supplementary Figure S1A). Furthermore, sRNAs have been reported to reduce leaky 
gene expression, which might be required to achieve synchronized gene expression 
throughout a population (245). These features are especially relevant in cases where the 
number of sRNAs in the cell exceeds the copy number of the regulated mRNA target, since 
all mRNAs would be silenced (246). Indeed, VqmR has been reported to be expressed in 
high copy numbers in a cell density dependent manner, increasing from ~70 copies per cell 
at LCD to ~500 copies per cell at HCD (46). While the exact number of copies per cell for 
aphA mRNA in V. cholerae is unknown, Feng et al., reported the copy number of the hapR 
homolog luxR in V. harveyi (recently, reclassified as V. campbellii) to increase from 4.36 
copies per cell at LCD to ~44 copies per cell at HCD (186). If we assume similar numbers 
for the levels of aphA mRNA, and take into account that the average (target) mRNA is 
expressed with between 0.05 to 5 copies per cell (247), VqmR levels likely exceed aphA 
mRNA levels and effectively silences aphA translation at the transition to HCD. In the same 
line of thought, it is interesting to consider why four homologous sRNAs are employed for 
the AI-2 and CAI-1 quorum sensing systems, while the DPO quorum sensing system relies 
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on a single sRNA, especially considering that Qrr4 has been reported to be expressed with 
~912 copies per cell at LCD, compared to ~56 copies per cell for Qrr2 and Qrr3, and ~14 
copies per cell for Qrr1 (186). It would be interesting to compare the copy numbers of all 
QS-related sRNAs and mRNA targets at the transition from LCD to HCD in future studies 
to gain a better understanding of the involved dynamics.  
  While the collective control of aphA and QS-regulated gene expression by all three 
QS systems has been discussed in detail in Chapter 4, an interesting aspect of this 
regulatory system is how the switch between physiological states would work after a rapid 
transition from HCD to LCD. In this case, VqmR would be present at high levels, since it 
has been reported to show high expression levels at HCD, and is very stable with an half-
life of more than 30min (46). During the switch from HCD to LCD, the earlier mentioned 
feedback loop, in which phosphorylated LuxO and HapR activate Qrr1-4 expression, would 
lead to the presence of high levels of the Qrr1-4 sRNAs, at the same time (243). Therefore, 
the Qrr1-4 sRNAs would compete with the VqmR sRNA for aphA activation or repression, 
respectively (Chapter 4, Table S1, Figs. 2, 3, (169, 170)). Interestingly, the Qrr1-4 sRNAs 
have been reported to turn-over following anti-antisense-pairing mediated activation of 
aphA translation (186). In contrast to that we found that the VqmR sRNA repressed aphA 
translation by base-pairing close to the AUG start codon, overlapping the ribsome-binding 
site (Chapter 4, Supplementary Figs. S5, S3A). This interaction site is in agreement with a 
mode of inhibiting translation initiation by blocking ribosome access, and indeed toeprinting 
analyses revealed that VqmR specifically interacts with this site to block 30S ribosomal 
access (Chapter 4, Supplementary Fig. S3B). While this regulatory mechanism of ribosomal 
occlusion has been reported to be sufficient to inhibit translation (53), it remains unclear 
whether base-pairing of VqmR to aphA mediates coupled degradation of VqmR, as well 
(56). It is interesting to consider what the outcome of this competition for regulation of aphA 
would be. Furthermore, it would be intriguing to test if VqmR would delay the switch from 
HCD to LCD, by limiting the levels of aphA transcripts that can be activated by Qrr1-4, or if 
aphA activation by Qrr1-4 or aphA repression by VqmR is obtaining superiority in this case. 
In vitro translation assays, using corresponding amounts of activating and repressing 
sRNAs, might provide an interesting experimental setup to predict the outcome of this 
competition (80).  
5.4 Conclusions and outlook 
 
The overarching goal of the present work was the functional characterization of sRNAs in 
the cholera pathogen, V. cholerae. A particular focus was given to sRNAs that are involved 
in stress response systems or quorum sensing. However, the majority of sRNAs present in 
V. cholerae remain uncharacterized regarding their mRNA target profiles and physiological 
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roles (Chapter 5.1). Future studies should address this, for instance by employing high-
throughput approaches, e.g. RIL-seq.  
  Here, we identified the MicV sRNA as a novel member of the σE-regulon of V. 
cholerae. In a cellular context MicV acts together with the VrrA sRNA to control OMP 
synthesis, and thus envelope homeostasis, under envelope stress conditions. We found 
that both sRNAs engage co-regulated mRNA targets with a conserved seed-region, that is 
also present in σE-dependent sRNAs of other bacteria, albeit overall limited sequence 
homology. Remaining key questions are mainly concerning sRNA evolution. For instance, 
it should be clarified whether there might be an ancestral σE-dependent sRNA that has been 
duplicated, and changed its overall sequence composition, keeping only the seed-region 
intact, or if the conserved seed-region has evolved in a different sRNA scaffold, performing 
previously unrelated functions.   
  Furthermore, we found that expression of the vadR sRNA is activated by the VxrAB 
two component system in the presence of cell-wall damaging agents. However, the exact 
signal bound by the sensor histidine kinase VxrA remains elusive. Future studies should 
aim to identify the exact signal and elucidate where in a natural environment it could be 
encountered. We further showed that VadR controls expression of biofilm synthesis in V. 
cholerae and is the first sRNA reported to regulate cell curvature, achieved through the 
regulation of the curvature determinant CrvA. Regulation of CrvA by VadR affected 
susceptibility of V. cholerae to cell-wall damaging antibiotics, however it remains unclear 
how curvature and antibiotic resistance are related. Additionally, it is not clear if and how 
cell curvature is important for biofilm formation and how this could be connected to cell wall 
damage.  
 The present work further expanded the known mRNA targets for the VqmR sRNA 
by five additional targets, including aphA - encoding the master regulator of low cell density. 
VqmR expression is controlled in response to the presence of the autoinducer DPO, and 
we found that the interplay of three quorum sensing systems is required to achieve a 
saturated quorum sensing response. It remains unclear how widespread the use of the DPO 
autoinducer is. It is also interesting to consider how the quorum sensing response would 
function in presence of other bacteria, for instance in the intestine, or in V. choleraes’ aquatic 
reservoirs.  
 In summary, we showed sRNAs to play key roles in the physiology of V. cholerae 
under standard laboratory conditions. Future studies should aim to translate these key 
functions to settings mimicking natural conditions, e.g. in infection models or in natural 
habitats.  
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Supplementary Materials and Methods 
 
Plasmid construction 
All plasmids and DNA oligonucleotides used in this study are listed in Table S3 and Table 
S4, respectively. If not stated otherwise, all insert fragments were amplified from genomic 
DNA of V. cholerae C6706. The backbone for the overexpression plasmids pNP-001/003-
006/008-010/013 was linearized with KPO-0092/1023 using pEVS143 as a PCR template. 
For the amplifications of the inserted sRNAs, the following combinations of oligonucleotides 
were used: KPO-1003/1004 (pNP-001), KPO-1024/1025 (pNP-003), KPO-1005/1006 
(pNP-004), KPO-1015/1016 (pNP-005), KPO-1021/1022 (pNP-006), KPO-1009/1010 
(pNP-008), KPO-1219/1220 (pNP-009), KPO-1001/1002 (pNP-010), and KPO-1017/1018 
(pNP-013). Subsequently, linearized vector and sRNA inserts were treated with XbaI 
restriction enzyme and fused by ligation. The construction of overexpression plasmids pLS-
014-020, pRH-005, and pSG-001/002 was achieved by Gibson assembly. pEVS143 
backbone was linearized using KPO-0092/1397 (pLS-014-020) or KPO-0092/1023 (pRH-
005, pSG-001/002). sRNA insert sequences were amplified using KPO-5835/5836 (pLS-
014), KPO-5837/5838 (pLS-015), KPO-5841/5842 (pLS-016), KPO-5843/5844 (pLS-017), 
KPO-5845/5846 (pLS-018), KPO-5847/5848 (pLS-019), KPO-5849/5850 (pLS-020), KPO-
1226/1227 (pRH-005), KPO-1858/1859 (pSG-001), and KPO-1860/1861 (pSG-002). 
Further, Gibson assembly was used to generate the inducible overexpression plasmids 
pMD-097, pNP-019, and pNP-123-127. For these plasmids, pMD-004 served as backbone 
and was linearized using KPO-0196/1397 (pMD-097 and pNP-019) or KPO-0196/1488 
(pNP-123-127). Amplification of insert genes were achieved with oligonucleotide 
combinations KPO-2554/2555 (pMD-097), KPO-1400/1401 (pNP-019), KPO-4852/4918 
(pNP-123), KPO-4852/4919 (pNP-125), KPO-4852/4920 (pNP-126), and KPO-4852/4921 
(pNP-127). Plasmid pNP-124 was assembled from two insert fragments, which were 
amplified with oligonucleotides KPO-4852/4853 and KPO-4854/4855, respectively. 
Plasmids pEE-007 and pLS-026-028 were generated by oligonucleotide-directed 
mutagenesis of pNP-005 (pEE-007) and pAE-002 (pLS-026-028), using KPO-4098/4099 
(pEE-007), KPO-5981/5982 (pLS-026), KPO-5983/5984 (pLS-027), and KPO-5985/5986 
(pLS-028). The promoter region of vadR was amplified using KPO-1906/1907 and KPO-
4410/4411 for plasmids pAE-002 and pNP-122, respectively. To generate pAE-002, the 
obtained fragment and the pCMW-1C vector were digested with SphI and SalI enzymes 
and fused by ligation. Likewise, pNP-122 was obtained by ligation after treating insert and 
pBBR1-MCS5-lacZ equally with restriction enzymes SpeI and SalI. 5’ UTRs and initial 
coding sequences for the construction of the translational reporter plasmids pNP-064/070-
073, pRG-011-013 and pRH-090/092 were amplified using KPO-1720/1721 (pNP-064), 
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KPO-2067/2068 (pNP-070), KPO-2069/2070 (pNP-071), KPO-2071/2072 (pNP-072), KPO-
2065/2066 (pNP-073), KPO-3735/3736 (pNP-113), KPO-3739/3740 (pNP-114), KPO-
3737/3738 (pNP-115), KPO-2383/2384 (pRG-011), KPO-2385/2386 (pRG-012), KPO-
2389/2390 (pRG-013), KPO-5534/5535 (pRH-090), and KPO-5538/5539 (pRH-092). 
Restriction digests of the amplified fragments and the pXG10-SF vector were conducted 
using NsiI and NheI enzymes. Inserts and vectors were combined by ligation. Plasmid pMH-
039 was generated by Gibson assembly, using KPO-1702/1703 to linearize the pXG10-SF 
vector and KPO-1801/2803 to amplify the insert fragment, respectively. To build the suicide 
plasmid pNP-133, flanking regions of the vadR locus were amplified using KPO-1294/1295 
and KPO-1296/1297. The two fragments were combined by overlap PCR with KPO-
1298/1299. Restriction digest of the obtained insert fragment and of the pKAS32 vector 
using KpnI and ArvII enzymes and subsequent ligation, yielded the functional plasmid. To 
build plasmid pRH-093, pNP-133 was linearized with KPO-5550/5551. The required insert 
was amplified from pNP-117 using KPO-5548/5549. Gibson assembly of both parts resulted 
in pRH-093. Plasmids pNP-128/132/134/135 and pRH-099 were obtained by Gibson 
assembly, using a pKAS32 vector, which was linearized with KPO-0267/0268. The single 
insert fragment of pNP-128 was amplified with KPO-5456/5457. The flanking regions of the 
crvA gene and the vxrABCDE operon were amplified using the two oligonucleotide 
combinations KPO-5450/5451, KPO-5452/5453 (pNP-134) and KPO-4621/4622, KPO-
4625/4626 (pNP-135), respectively. To introduce a crvA-3xFLAG construct onto the 
chromosome of V. cholerae, plasmid pNP-132 was designed. The corresponding flanking 
regions were amplified using KPO-5442/5443 and KPO-5446/5447. Oligonucleotides KPO-
5444/5445 were used to amplify the 3xFLAG epitope from template plasmid pRH-030. The 
araC-PBAD insert of pRH-099 was amplified from pMD-004 using KPO-4529/0196. Flanking 
regions of the crvAB promoter were amplified using oligos KPO-6013/6014 and KPO-
6015/6016, respectively.  
All mutations for compensatory base pair exchanges were introduced by oligonucleotide-
directed mutagenesis using the oligonucleotides listed in Table S4, and the respective 
parental plasmids as a template.  
 
Construction of V. cholerae mutant strains 
All strains used in this study is are listed in Table S2. V. cholerae C6706 was used as the 
wild-type strain in this study. V. cholerae mutant strains were generated as described 
previously2. Conjugal transfer was used to introduce plasmids into V. cholerae from E. coli 
S17λpir donor strains. Transconjugants were selected using appropriate antibiotics, and 50 
U/ml polymyxin B was used to select against E. coli donor strains. 
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Transcript stability experiments 
Stability of VadR was determined as described previously3. Briefly, biological triplicates of 
V. cholerae wild-type (KPS-0014) and Δhfq (KPS-0054) strains were grown to OD600 = 0.2 
and transcription was terminated by addition of 250 µg/ml rifampicin. Transcript levels were 
probed and quantified using Northern blot analysis. 
 
Quantitative real-time PCR 
Total RNA was isolated using the SV Total RNA Isolation System (Promega), according to 
the manufacturer’s instructions. qRT-PCR was performed using the Luna Universal One-
Step RT-qPCR Kit (New England BioLabs) and the MyiQTM Single-Color Real-Time PCR 
Detection System (Bio-Rad). recA was used as a reference gene.  
 
Analysis of VxrB-HIS ChIP-seq data  
The raw data of the VxrB-HIS ChIP experiment conducted by Shin et al.1 was obtained from 
Gene Expression Omnibus (GEO) under the accession number GSE135009. The read files 
were imported into CLC Genomics Workbench v11 (Qiagen) and trimmed for quality using 
default parameters. Reads were mapped to the V. cholerae reference genome (NCBI 
accession numbers: NC_002505.1 and NC_002506.1) using the “RNA-Seq Analysis” tool 
with default parameters. 
 
RNA in vitro analysis  
A DNA template carrying the T7 promoter for in vitro synthesis of RNA was prepared by 
PCR using oligonucleotides KPO-5083 and KPO-5084. 200 ng of template DNA were in 
vitro transcribed using the AmpliScribe T7-Flash transcription kit (Epicentre) following the 
manufacturer’s recommendations. RNA size and integrity were verified on denaturing 
polyacrylamide gels. For 5’ end labelling, 20 pmol of RNA were dephosphorylated using 10 
units of calf alkaline phosphatase (NEB), followed by P:C:I extraction and ethanol 
precipitation of RNA. Dephosphorylated RNA was incubated with [32P]-γATP (20 µCi) and 
1 unit of polynucleotide kinase (NEB) for 1h at 37°C. Unincorporated nucleotides were 
removed using Microspin G-50 Columns (GE Healtcare). Labelled RNA was loaded on a 
6%/7M urea gel, cut from the gel, eluted overnight at 4°C in RNA elution buffer (0.1 M 
sodium acetate, 0.1% SDS, 10 mM EDTA), and recovered by P:C:I extraction.  
RNA structure probing was carried out as described previously (PMID 24141880) with few 
modifications. In brief, for 0.4 pmol 5′-end-labelled VadR sRNA was denatured, quickly 
chilled on ice and supplemented with 1x structure buffer (0.01 M Tris [pH 7], 0.1 M KCl, 
0.01 M MgCl2) and 1 μg yeast RNA. Samples were incubated at 37°C, and treated with 
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RNase T1 (0.1 U; Ambion no. AM2283) for 60,120 and 180 sec, or with lead(II) acetate (final 
concentration, 5 mM; Sigma no. 316512) for 15, 30 and 90 sec.  
Reactions were stopped by the addition of 2 vol. stop/precipitation buffer (1M guanidinium 
thiocyanate, 0.167% N-lauryl-sarcosine, 10 mM DTT, 83% 2-propanol). RNA was 
precipitated for 2 h at -20°C, and collected by centrifugation (30 min, 4°C, 13.000 rpm). 
Samples were dissolved in GLII loading buffer, and separated on 10% polyacrylamide 
sequencing gels. 
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Figure S1 
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Figure S1: Structure and transcriptional control of the VadR sRNA  
(a) The secondary structure of the VadR sRNA predicted by structure probing experiments (b).  
(b) Secondary structure probing of the VadR sRNA. VadR was synthesized in vitro and labelled with 
32P. Enzymatic treatment was performed using RNase T1, or lead-acetate (Pb(II)). The untreated 
control is labelled with C, denatured ladders for RNase T1 and alkaline ladder are provided and 
labelled with T1 and OH, respectively. Guanin residues are labelled on the left side.  
(c) Rifampicin treatment to determine half-life of the VadR sRNA, in wild-type or hfq mutant strains. 
The dashes represent the mean pf biological replicates ± SD, n = 3.  
(d) VadR promoter activities in E. coli and V. cholerae cultures grown for 16h in LB were determined 
using a fluorescent transcriptional reporter. Data are the mean of biological replicates ± SD, n = 3. 
(e) Upper part: Experimental outline to identify transcription factors affecting vadR transcription. 
Lower part: Identified fragments that yielded blue colonies.   
(f) V. cholerae wild-type and vxrABCDE mutant strains were grown to OD600 = 0.5 and VadR promoter 
activities were measured. Bars show the mean of biological replicates ± SD, n = 3.  
(g) ChIP-seq data from V. cholerae wild-type and vxrB-HIS strains, which were treated with Penicillin 
G for 3h1. Data was re-analyzed and read coverages for the vadR genomic locus were plotted.  
(h) Three putative VxrB binding sites in the promoter region of vadR were deleted. The resulting 
strains and V. cholerae wild-type were cultivated to OD600 = 1.0 and assayed for vadR promoter 
activities using a fluorescent transcriptional reporter. Bars represent the mean of biological replicates 
± SD, n = 4. The mean of wild-type cells was set to 1. 
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Figure S2 
 
Figure S2: RNA-seq target validation and VadR-mediated regulation of RbmA 
(a) qRT-PCR analysis after short period VadR expression. Expression was calculated relative to an 
empty vector control (pBAD-ctr). Bars represent mean of biological replicates ± SE, n = 3.   
(b) Western blot analysis of RbmA-3xFLAG levels in V. cholerae wild-type and vadR mutant strains 
carrying either an empty control plasmid (pCtr) or a constitutive vadR overexpression plasmid. Cells 
were grown at 30 °C without agitation. Whole cell protein fractions were harvested at OD600 = 0.4. 
Bars indicate mean of biological replicates ± SD, n = 3. Statistical significance was determined using 
one-way ANOVA and post-hoc Holm-Sidak test. 
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Figure S3 
 
Figure S3: Indirectly regulated genes by VadR and expression of VadR variants  
(a) Genes which are not post-transcriptionally regulated by VadR. Fluorescence intensities of E. coli 
strains carrying the gene-specific reporter and the control plasmid (pCtr) were set to 1. Bars show 
mean of biological replicates ± SD, n = 4. 
(b) Northern blot analysis confirms similar expression levels of all plasmid-borne VadR variants used 
in this study. RNA was obtained from E. coli cells at OD600 = 1.0, which were overexpressing the 
indicated vadR variants. 
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Figure S4 
 
Figure S4: VadR does not affect the length and area of V. cholerae cells 
(a-b) Analysis of cell length (a) and cell area (b) in –Cef samples of Fig. 4b. A blue line indicates the 
median, boxes represent 25th and 75th percentiles, whiskers represent 5th and 95th percentiles and 
notches indicate 95% confidence intervals for each median. n of each set is listed above the x-axis. 
Statistical significance was determined using Kruskal-Wallis test and post-hoc Dunn’s test. 
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Figure S5 
 
Figure S5: The VadR promoter responds to A22 treatment and V. cholerae depends on a 
tight regulation of crvA to increase Penicillin G tolerance. 
(a) V. cholerae wild-type and vxrABCDE mutant strains were grown to OD600 = 0.2. Cultures were 
split and one set was treated with A-22 (10 µg/ml final conc.), while the other set received the same 
volume of water as mock treatment. VadR promoter activities in both sets were measured after 3h 
using a fluorescent transcriptional reporter. Promoter activities of mock-treated strains were set to 1. 
Bars represent mean of biological replicates ± SD, n = 4.  
(b) Expression of the crvAB operon was regulated by replacing its native promoter with a PBAD 
promoter and by using different L-arabinose concentrations for induction. Cells were treated with 
Penicillin G for 3h and colony forming units (CFUs) were counted. Bars show mean of biological 
replicates ± SD, n = 6. Statistical significance was determined using one-way ANOVA and post-hoc 
Holm-Sidak test.  
(c) The indicated V. cholerea strains (x-axis) were grown to OD600 = 0.2 and treated with Penicillin G 
for 30min. Total RNA was isolated and analyzed for crvA expression by qRT-PCR. Bars represent 
mean of biological replicates ± SE, n = 4, relative to V. cholerae wild-type. Statistical significance 
was determined using one-way ANOVA and post-hoc Holm-Sidak test. 
(d) The indicated V. cholerea strains (y-axis) were grown to OD600 = 0.4 + 3h and assayed for 
CFUs by spotting serial dilutions on agar plates.   
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Table S1 Genes differentially regulated by vadR pulse expression 
ID Gene Description# Fold 
change* 
vc0932 rbmE uncharacterized protein -4.70  
vc0934 vpsL capsular polysaccharide biosynthesis glycosyltransferase -4.61  
vc0933 rbmF uncharacterized protein -4.57  
vc0928 rbmA rugosity and biofilm structure modulator A -3.58  
vc0935 vpsM polysaccharide biosynthesis protein -3.48  
vc0936 vpsN polysaccharide biosynthesis/export protein -3.23  
vc0917 vpsA UDP-N-acetylglucosamine 2-epimerase -3.19  
vc0919 vpsC serine O-acetyltransferase -3.03  
vc0918 vpsB UDP-N-acetyl-D-mannosaminuronic acid dehydrogenase -2.92  
vc0916 vpsU tyrosine-protein phosphatase -2.83  
vc0931 rbmD hypothetical protein -2.71  
vca0043  hypothetical protein -2.55  
vca0864  methyl-accepting chemotaxis protein -2.53  
vc0920 vpsD polysaccharide biosynthesis protein -2.47  
vc1888 bap1 extracellular matrix protein -2.38  
vc0937 vpsO polysaccharide biosynthesis transport protein -2.38  
vc1264 irpA iron-regulated protein A -2.34  
vc0938 vpsP polysaccharide biosynthesis protein -2.14  
vc2352  concentrative nucleoside transporter, CNT familiy -1.97  
vca0075  hypothetical protein -1.89  
vca1075 crvA hypothetical protein -1.81  
vc0930 rbmC rugosity and biofilm structure modulator C -1.79  
vca0044  pseudogene -1.77  
vca0074  diguanylate cyclase -1.77  
vc0018 ibpA molecular chaperone IbpA -1.76  
vca0129 rbsC ribose transport system permease protein 1.81  
vca0128 rbsA ribose transport system ATP-binding protein 1.96  
vca0127 rbsD D-ribose pyranase 2.22  
 
#Description is based on the annotation at KEGG (https://www.genome.jp/kegg) 
 
*Fold change is based on transcriptomic analysis of pBAD-derived vadR expression using 
RNA-seq. Genes with a fold-change of at least 1.75-fold in either condition and a FDR 
adjusted p-value ≤ 0.001 were considered to be differentially expressed.  
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Table S2 Bacterial strains used in this study 
Strain Relevant markers/ genotype Reference/ source 
V. cholerae   
KPS-0014  Wild-type C6706 4 
KPS-0053 ΔhapR C6706 3 
KPS-0054 Δhfq C6706 5 
KPVC-10126 ΔvadR C6706 This study 
KPVC-12430 ΔvxrABCDE C6706 This study 
KPVC-12817 ΔcrvA C6706 This study 
KPVC-12912 crvA M1* C6706 This study 
KPVC-12913 crvA::crvA-3xFLAG C6706 This study 
KPVC-12914 ΔvadR crvA::crvA-3xFLAG C6706 This study 
KPVC-13214 vadR M1 C6706 This study 
KPVC-13215 vadR M1 crvA M1* C6706 This study 
KPVC-13223 rbmA::rbmA-3xFLAG, rbmC::rbmC-3xFLAG, bapI::bapI-3xFLAG 
C6706 
This study 
KPVC-13384 PcrvAB::araC-PBAD C6706 This study 
KPVC-13439 ΔhapR ΔrbmA C6706 This study 
E. coli   
BW25113 lacI+ rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 ΔrhaBADLD78 rph-1 
Δ(araB–D)567 Δ(rhaD–B)568 ΔlacZ4787(::rrnB-3) hsdR514 rph-1 
6 
TOP10 mcrAΔ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15ΔlacX74deoRrecA1 
araD139Δ(ara-leu)7697 galU galK rpsL endA1 nupG 
Invitrogen 
S17λpir ΔlacU169 (ΦlacZΔM15), recA1, endA1, hsdR17, thi-1, gyrA96, relA1, 
λpir 
7 
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Table S3 Plasmids used in this study 
Plasmid trivial 
name 
Plasmid 
stock 
name- 
Relevant fragment Comment Origin, 
marker 
Reference 
pBBR1MCS5-5-
lacZ 
 lacZ Promoterless plasmid 
for transcriptional 
reporters 
pBBR1, 
GentR 
8 
PvadR-mKate2 pAE-002 PvadR-mKate2 vadR transcriptional 
reporter plasmid 
p15A, CmR This study 
pCMW-1C pCMW-
1C 
CmR cassette Promoterless plasmid 
for transcriptional 
reporters 
p15A, CmR 9 
pCtr pCMW-1K KanR cassette Control plasmid p15A, KanR 10 
pKAS32-ΔrbmA pCN-007 up-/downstream 
flanks of rbmA  
suicide plasmid for 
rbmA knockout 
R6K, AmpR 11 
pKAS32-rbmA-
3xFLAG 
pCN-018 3xFLAG rbmA-3xFLAG allelic 
replacement 
R6K, AmpR 11 
pKAS32-rbmC-
3xFLAG 
pCN-019 3xFLAG rbmC-3xFLAG allelic 
replacement 
R6K, AmpR 11 
pKAS32-bapI-
3xFLAG 
pCN-020 3xFLAG bap1-3xFLAG allelic 
replacement 
R6K, AmpR 12 
pVadRΔR1 pEE-007 vadR ΔR1 vadR ΔR1 expression 
plasmid 
p15A, KanR This study 
pEVS143 pEVS143 Ptac promoter Constitutive over-
expression plasmid 
p15A, KanR 3 
pKAS32 pKAS32  suicide plasmid for 
allelic exchange 
R6K, AmpR 13 
pVcr025 pLS-014 vcr025 vcr025 expression 
plasmid 
p15A, KanR This study 
pVcr062 pLS-015 vcr062 vcr062 expression 
plasmid 
p15A, KanR This study 
pVcr058 pLS-016 vcr058 vcr058 expression 
plasmid 
p15A, KanR This study 
pVcr071 pLS-017 vcr071 vcr071 expression 
plasmid 
p15A, KanR This study 
pVcr067 pLS-018 vcr067 vcr067 expression 
plasmid 
p15A, KanR This study 
pVcr094 pLS-019 vcr094 vcr094 expression 
plasmid 
p15A, KanR This study 
pVcr099 pLS-020 vcr099 vcr099 expression 
plasmid 
p15A, KanR This study 
pΔsite1-mKate2 pLS-026 PvadRΔsite1-
mKate2 
vadR transcriptional 
reporter plasmid 
p15A, CmR This study 
pΔsite2-mKate2 pLS-027 PvadRΔsite2-
mKate2 
vadR transcriptional 
reporter plasmid 
p15A, CmR This study 
pΔsite3-mKate2 pLS-028 PvadRΔsite3-
mKate2 
vadR transcriptional 
reporter plasmid 
p15A, CmR This study 
pBAD pMD-004  Control plasmid p15A, KanR 9 
pVcr084 pMD-097 vcr084 vcr084 expression 
plasmid 
p15A, KanR This study 
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pvca0864-gfp pMH-039 vca0864-gfp Translational reporter 
vca0864-gfp 
pSC101*, 
CmR 
This study 
pVcr002 pNP-001 vcr002 vcr002 expression 
plasmid 
p15A, KanR This study 
pVcr036 pNP-003 vcr036 vcr036 expression 
plasmid 
p15A, KanR This study 
pVcr043 pNP-004 vcr043 vcr043 expression 
plasmid 
p15A, KanR This study 
pVadR pNP-005 vadR vadR expression 
plasmid 
p15A, KanR This study 
pVcr079 pNP-006 vcr079 vcr079 expression 
plasmid 
p15A, KanR This study 
pVcr034 pNP-008 vcr034 vcr034 expression 
plasmid 
p15A, KanR This study 
pVcr082 pNP-009 vcr082 vcr082 expression 
plasmid 
p15A, KanR This study 
pVcr092 pNP-010 vcr092 vcr092 expression 
plasmid 
p15A, KanR This study 
pVcr045 pNP-013 vcr045 vcr045 expression 
plasmid 
p15A, KanR This study 
pBAD-vadR pNP-019 PBAD-vadR Inducible vadR 
expression plasmid 
p15A, KanR This study 
prbmC-gfp pNP-064 rbmC-gfp Translational reporter 
rbmC-gfp 
pSC101*, 
CmR 
This study 
pvpsU-gfp pNP-070 vpsU-gfp Translational reporter 
vpsQ-gfp 
pSC101*, 
CmR 
This study 
prbmA-gfp pNP-071 rbmA-gfp Translational reporter 
rbmA-gfp 
pSC101*, 
CmR 
This study 
prbmD-gfp pNP-072 rbmD-gfp Translational reporter 
rbmD-gfp 
pSC101*, 
CmR 
This study 
pvpsL-gfp pNP-073 vpsL-gfp Translational reporter 
vpsL-gfp 
pSC101*, 
CmR 
This study 
pirpA-gfp pNP-113 irpA-gfp Translational reporter 
irpA-gfp 
pSC101*, 
CmR 
This study 
pvc2352-gfp pNP-114 vc2352-gfp Translational reporter 
vc2352-gfp 
pSC101*, 
CmR 
This study 
pvca0043-gfp pNP-115 vca0043-gfp Translational reporter 
vca0043-gfp 
pSC101*, 
CmR 
This study 
pcrvA M1*-gfp pNP-116 crvA M1*-gfp Translational reporter 
crvA M1-gfp 
pSC101*, 
CmR 
This study 
pVadR M1 pNP-117 vadR M1 vadR M1 expression 
plasmid 
p15A, KanR This study 
pVadR M3 pNP-118 vadR M3 vadR M3 expression 
plasmid 
p15A, KanR This study 
pvpsU M2*-gfp pNP-119 vpsU M2*-gfp Translational reporter 
vpsU M2-gfp 
pSC101*, 
CmR 
This study 
prbmA M1*-gfp pNP-120 rbmA M1*-gfp Translational reporter 
rbmA M1-gfp 
pSC101*, 
CmR 
This study 
pvpsL M3*-gfp pNP-121 vpsL M3*-gfp Translational reporter 
vpsL M3-gfp 
pSC101*, 
CmR 
This study 
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PvadR-lacZ pNP-122 PvadR-lacZ vadR transcriptional 
reporter plasmid 
pBBR1, 
GentR 
This study 
pBAD-vxrA pNP-123 vxrA Inducible vxrA 
expression plasmid 
p15A, KanR This study 
pBAD-vxrAB pNP-124 vxrAB Inducible vxrAB 
expression plasmid 
p15A, KanR This study 
pBAD-vxrABC pNP-125 vxrABC Inducible vxrABC 
expression plasmid 
p15A, KanR This study 
pBAD-vxrABCD pNP-126 vxrABCD Inducible vxrABCD 
expression plasmid 
p15A, KanR This study 
pBAD-
vxrABCDE 
pNP-127 vxrABCDE Inducible vxrABCDE 
expression plasmid 
p15A, KanR This study 
pKAS32-ΔcrvA  pNP-128 crvA region crvA region R6K, AmpR This study 
pKAS32-crvA 
M1* 
pNP-129 crvA M1* crvA M1* allelic 
replacement 
R6K, AmpR This study 
pKAS32-crvA-
3xFLAG 
pNP-132 crvA-3xFLAG crvA-3xFLAG allelic 
replacement 
R6K, AmpR This study 
pKAS32-ΔvadR pNP-133 up-/downstream 
flanks vadR 
suicide plasmid for 
vadR knockout 
R6K, AmpR This study 
pKAS32-ΔcrvA pNP-134 up-/downstream 
flanks crvA 
suicide plasmid for crvA 
knockout 
R6K, AmpR This study 
pKAS32-
ΔvxrABCDE 
pNP-135 up-/downstream 
flanks vxrABCDE 
suicide plasmid for 
vxrABCDE knockout 
R6K, AmpR This study 
pVadR M2 pNP-168 vadR M2 vadR M2 expression 
plasmid 
p15A, KanR This study 
pbap1-gfp pRG-011 bap1-gfp Translational reporter 
bap1-gfp 
pSC101*, 
CmR 
This study 
pcrvA-gfp pRG-012 crvA-gfp Translational reporter 
crvA-gfp 
pSC101*, 
CmR 
This study 
prbmF-gfp pRG-013 rbmF-gfp Translational reporter 
rbmEF-gfp 
pSC101*, 
CmR 
This study 
pVcr098 pRH-005 vcr098 vcr098 expression 
plasmid 
p15A, KanR This study 
pKAS32-aphA-
3xFLAG 
pRH-030 3xFLAG  aphA-3xFLAG allelic 
replacement 
R6K, AmpR 13 
pvca0075-gfp pRH-090 vca0075-gfp Translational reporter 
vca0075-gfp 
pSC101*, 
CmR 
This study 
prbsD-gfp pRH-092 rbsD-gfp Translational reporter 
rbsD-gfp 
pSC101*, 
CmR 
This study 
pKAS32- vadR 
M1 
pRH-093 vadR M1 vadR M1 allelic 
replacement 
R6K, AmpR This study 
pKAS32- araC-
PBAD 
pRH-099 araC-PBAD, flanking 
regions of PcrvAB 
araC-PBAD allelic 
replacement 
R6K, AmpR This study 
pVcr017 pSG-001 vcr017 vcr017 expression 
plasmid 
p15A, KanR This study 
pVcr080 pSG-002 vcr080 vcr080 expression 
plasmid 
p15A, KanR This study 
pXG10-SF pXG10SF 'lacZ::gfp template plasmid for 
translational reporters 
pSC101*, 
CmR 
14 
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pCMW-1C-
mKate2 
pYH-010 mKate2 Promoterless plasmid 
for transcriptional 
reporters 
P15A, CmR 6 
pZ1 pZ1 vcrAB fragment 1 vxrAB fragment 1 
expression plasmid 
p15A, CmR This study 
pZ2 pZ2 vcrAB fragment 2 vxrAB fragment 2 
expression plasmid 
p15A, CmR This study 
pZach pZND132 V.ch. genomic 
fragments 
Genomic fragment 
expression plasmid 
p15A, CmR 15 
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Table S4 DNA oligonucleotides used in this study 
Sequences are given in 5’  3’ direction; 5’ P denotes a 5’ monophosphate 
ID Sequence Description 
KPO-0092 CCACACATTATACGAGCCGA pNP-001/003-006/008-
010/013, pSG001/002, 
pLS014-020, pRH-005 
KPO-0196 GGAGAAACAGTAGAGAGTTGCG pNP-019/123-127, pMD-097, 
pRH-099 
KPO-0243 TTCGTTTCACTTCTGAGTTCGG 5S-rRNA probe 
KPO-0267 TAATAGGCCTAGGATGCATATG pNP-128/132/133/134/135, 
pRH-099 
KPO-0268 CGTTAACAACCGGTACCTCTA pNP-128/132/133/134/135, 
pRH-099 
KPO-0331 GAGCCAATCTACAATTCATCAGA VadR probe 
KPO-1001 P-TCACAGAACCGCTGTGACCA pNP-010 
KPO-1002 GTTTTTTCTAGATTGACTACTTCATTCGCCAC pNP-010 
KPO-1003 P-GCAAACACATTGGTAAGATATTAG pNP-001 
KPO-1004 GTTTTTTCTAGATATAACCTGTTCAGAATGTGCT pNP-001 
KPO-1005 P-GTCATCTCGTTAGTCATTACGA pNP-004 
KPO-1006 GTTTTTTCTAGACACTGACAAACCGGTGTTGG pNP-004 
KPO-1009 P-ACTTACTTGGATAAATATGCATTG pNP-008 
KPO-1010 GTTTTTTCTAGAGTATTGTTTGTCTGTCATAAAGTT pNP-008 
KPO-1015 P-AATAGACAACCTTTTGTCCTATC pNP-005 
KPO-1016 GTTTTTTCTAGAATAGAAAGCACTGAGTCAGGA pNP-005 
KPO-1017 P-TTGCCCGCAAGCCACGGC pNP-013 
KPO-1018 GTTTTTTCTAGAAGGCGATTGGTCGTGTTGTT pNP-013 
KPO-1021 P-GTTTGAACCCCGGCGGCT pNP-006 
KPO-1022 GTTTTTTCTAGAAAACCGACTCCTTGCAAGAA pNP-006 
KPO-1023 GTTTTTTCTAGAGGATCCGGTGATTGATTGAG pNP-001/003-006/008-
010/013, pSG001/002, pRH-
005 
KPO-1024 P-ACCCAAAGGGTAGAGCAAAC pNP-003 
KPO-1025 GTTTTTTCTAGAGAAAACGAAGTAATCTTCACCTT pNP-003 
KPO-1219 P-AGCTTCGCTAGCGAAGAG pNP-009 
KPO-1220 GTTTTTTCTAGAGAATGTTGCGATCAAGTTCG pNP-009 
KPO-1226 TCGTATAATGTGTGGGTAAGGTTAGTGAGAACATTTCT pRH-005 
KPO-1227 ACCGGATCCTCTAGAAGTTTCAAATTTCGTGGACAGC pRH-005 
KPO-1294 GTACATTTTGGTGTGGGAGC pNP-133 
KPO-1295 GCACTGAGTCAGGATTTTGCGTATCGGCGGTTATTCGGTTC pNP-133 
KPO-1296 GCAAAATCCTGACTCAGTGC pNP-133 
KPO-1297 CAAACCCAGCTCTTTAGCTTC pNP-133 
KPO-1298 GTTTTTGGTACCGACGCGAGATTATTTCTTCC pNP-133 
KPO-1299 GTTTTTCCTAGGGATAGTCAGGCCGCTTTCG pNP-133 
KPO-1397 GATCCGGTGATTGATTGAGC pNP-019, pMD-097, pLS014-
020 
KPO-1400 CGCAACTCTCTACTGTTTCTCCGAATAGACAACCTTTTGTCCTATC pNP-019 
KPO-1401 GCTCAATCAATCACCGGATCATAGAAAGCACTGAGTCAGGA pNP-019 
KPO-1488 TTTTTTCTAGATTAAATCAGAACGCAG pNP-123-127 
KPO-1702 ATGCATGTGCTCAGTATCTCTATC pMH-039 
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KPO-1703 GCTAGCGGATCCGCTGG pMH-039 
KPO-1720 GAGATACTGAGCACATGCATAGGTTGTTATTAGCAATCCGCGATAC pNP-064 
KPO-1721 GAGCCAGCGGATCCGCTAGCCAACGACAAAAGACCGACAGCAAG pNP-064 
KPO-1801 CTGTCACCAATTACGCTGGTTTTTCCTTTTTATTAAC pMH-039 
KPO-1858 TCGGCTCGTATAATGTGTGGGCTAGCGAAAACTATAATCATAAAC pSG-001 
KPO-1859 CTCAATCAATCACCGGATCCGCTTTGATTGAGCAGACGTTG pSG-001 
KPO-1860 TCGGCTCGTATAATGTGTGGGCAAGTCAGTGGTGTTGG pSG-002 
KPO-1861 CTCAATCAATCACCGGATCCGTACTGTCAATATCGACCAC pSG-002 
KPO-1906 GTTTTTGCATGCGCTGCGTGTTGAAAACGATG pAE-002 
KPO-1907 GTTTTTGTCGACCTATTCGTGAAGCAGTGTATC pAE-002 
KPO-2065 GTTTTTATGCATAGATATTTCTATTGATAAAGATGTAGTCTT pNP-073 
KPO-2066 GTTTTTGCTAGCGCTATCAATTAATCGGTAGAAAAATTTAC pNP-073 
KPO-2067 GTTTTTATGCATACTCTGATAATGAGTAGATTGCG pNP-070 
KPO-2068 GTTTTTGCTAGCCTCTGCCATTGGCGAACGA pNP-070 
KPO-2069 GTTTTTATGCATTTAGCCAATGCAATTGTCTTAGATTTG pNP-071 
KPO-2070 GTTTTTGCTAGCATAAGAAGCCGTTGAAAATAACAATGC pNP-071 
KPO-2071 GTTTTTATGCATATGGCATGGCGGAGCAAGTTG pNP-072 
KPO-2072 GTTTTTGCTAGCACTGCCAAGAGGGATTGGTAAC pNP-072 
KPO-2378 GGTAACCCAGAAACTACCACTG recA qRT-PCR 
KPO-2379 CACCACTTCTTCGCCTTCTT recA qRT-PCR 
KPO-2383 GTTTTTATGCATGCTCTCAGCATATCGTTATTG pRG-011 
KPO-2384 GTTTTTGCTAGCGAATGCGGTGCTTTGAGTC pRG-011 
KPO-2385 GTTTTTATGCATGCTTAGATCTAAAGTTCAAAAAATCAG pRG-012 
KPO-2386 GTTTTTGCTAGCCGATGCAGATACCCATAAAGG pRG-012 
KPO-2389 GTTTTTATGCATAAAGAAATAATATGTATCGTTTATCG pRG-013 
KPO-2390 GTTTTTGCTAGCATTCATGCTAGGAAAAAATGCAATC pRG-013 
KPO-2554 CGCAACTCTCTACTGTTTCTCCTATTACAACAAGAGAGGCTC pMD-097 
KPO-2555 GCTCAATCAATCACCGGATCCAGACGCTACATCAAACTG pMD-097 
KPO-2803 GAGCCAGCGGATCCGCTAGCGACCACCCAACGCAGCAATC pMH-039 
KPO-3613 CTTGATTGGTTGGCGTGTATTG vpsL-O qRT-PCR 
KPO-3614 CTTGCCCTTGAGTAGTCATACC vpsL-O qRT-PCR 
KPO3615 CTTGTGGCGCACTTTCAATC rbmEF qRT-PCR 
KPO3616 GTGGATGACCAACGAGTACAA rbmEF qRT-PCR 
KPO-3617 GCTCTTACTGATGGTCGTATGT rbmA qRT-PCR 
KPO-3618 CTGCAACGACTTGAAGAGAAAC rbmA qRT-PCR 
KPO-3621 TAGTGCTGGCACGCTAAAG vpsQA-K qRT-PCR 
KPO-3622 TTGAGTCACTTGCTGGACTG vpsQA-K qRT-PCR 
KPO-3623 CTTGGTTGCCGCGTTATTG rbmD qRT-PCR 
KPO-3624 GCATAGAAGGCCTGACAGATAC rbmD qRT-PCR 
KPO-3625 GAGCTGCAAGGTAAGGGATAC vca0043-44 qRT-PCR 
KPO-3626 AACTACAGACGGGCACAATC vca0043-44 qRT-PCR 
KPO-3627 CAGTCCCTATCCGAGCATATTG vca0864 qRT-PCR 
KPO-3628 GGTAAGCTCCTCTAACCGATAAC vca0864 qRT-PCR 
KPO-3629 CCGTCTCTTACTGGTTCTTTGG bapI qRT-PCR 
KPO-3630 GTGTCACAGGAACGGCATAA bapI qRT-PCR 
KPO-3631 CGATCTTGAGTGGATGGAGAAG irpA qRT-PCR 
KPO-3632 ATAGCGAGCCCATACCAAAC irpA qRT-PCR 
KPO-3633 GCGTGAAAGTAGCGTGTTAGA crvA qRT-PCR 
KPO-3634 TTCTGCTTCGTCAGGTATTGG crvA qRT-PCR 
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KPO-3635 CTGAGCTGTTTGCGGTAATG vc2352 qRT-PCR 
KPO-3636 CCGCTACCAAGTATTCGATCT vc2352 qRT-PCR 
KPO-3637 GGCATCGAACATCACGATACA vca0074-75 qRT-PCR 
KPO-3638 CCATGGCAGTTCAGTGGTAAA vca0074-75 qRT-PCR 
KPO-3641 TCGGCCATACCGATGAAATC rbsDACB qRT-PCR 
KPO-3642 AGTCAGCGCGAGATCAATAC rbsDACB qRT-PCR 
KPO-3643 GGTTCTGAGCTATGGAGCTATG rbmC qRT-PCR 
KPO-3644 ATCTCAACGATTCCGTCACC rbmC qRT-PCR 
KPO-3735 GTTTTTATGCATGAAATAACAAATGATAATAATTTGCAATTC pNP-113 
KPO-3736 GTTTTTGCTAGCCGCTGATGTAGTGAGCGTC pNP-113 
KPO-3737 GTTTTTATGCATAGCGAGTCACCAACTAATTTG pNP-115 
KPO-3738 GTTTTTGCTAGCTTCCAAAGCCACGCGATAAC pNP-115 
KPO-3739 GTTTTTATGCATGCTTAATCGCTCCATTTTGTAAC pNP-114 
KPO-3740  GTTTTTGCTAGCCAGTAGAACTGCGATTCCTAG pNP-114 
KPO-4098 TCGGCTCGTATAATGTGTGGATCTGATGAATTGTAGATTGGCT pEE-007 
KPO-4099 AATAGACAACCTTTTGTCCTATCTGATGAATTGATATGTTTTAAGC pEE-007 
KPO-4250 GAATACTGAACCTTTTGTCCTATCTG pNP-117 
KPO-4251 GTTCAGTATTCCCACACATTATACG pNP-117 
KPO-4252 GTTTCAGTTTCCCACTTTATGTGG pNP-116 
KPO-4253 GGAAACTGAAACTTTTGACAGCTTTG pNP-116 
KPO-4410 GTTTTTTACTAGTGCTGCGTGTTGAAAACGATG pNP-122 
KPO-4411 GTTTTTTGTCGACCTATTCGTGAAGCAGTGTATC pNP-122 
KPO-4529 TATAAGATCATAAAAGACCCTTCATTTATG pRH-099 
KPO-4621 AGAGGTACCGGTTGTTAACGCATCATCAAGTCCACACCACT pNP-135 
KPO-4622 TATCCGGTAAAGAGATATTCGAG pNP-135 
KPO-4625 GAATATCTCTTTACCGGATACACCAAACCTGCTAAAAACACG pNP-135 
KPO-4626 TATGCATCCTAGGCCTATTACGATACCGGTGAAGCTAATGA pNP-135 
KPO-4846 GATTGGCTTTGACCGTCTACT ibpA qRT-PCR 
KPO-4847 GCTCGATATTGTATGGAGGGTATC iboA qRT-PCR 
KPO-4852 CAACTCTCTACTGTTTCTCCGGATAATGCGTTATAGTTTTTGC pNP-123-127 
KPO-4853 TCAACGAGAAGCAGTGTCTG pNP-124 
KPO-4854 CAGACACTGCTTCTCGTTGAAGATGATAAAAACCTCGCTGAC pNP-124 
KPO-4855 CTGATTTAATCTAGAAAAAATGATCACGCTTTCATTTTGTAAC pNP-124 
KPO-4918 CTGATTTAATCTAGAAAAAATCAACGAGAAGCAGTGTCTG pNP-123 
KPO-4919 CTGATTTAATCTAGAAAAAACTATAGCGGCATATTGTCCAA pNP-125 
KPO-4920 CTGATTTAATCTAGAAAAAAGAGCCACACTATAAAGAGATG pNP-126 
KPO-4921 CTGATTTAATCTAGAAAAAAGAAAAATTGGCTACGATTATTACC pNP-127 
KPO-5083 GTTTTTTTTAATACGACTCACTATAGGAATAGACAACCTTTTGTCCT In-vitro VadR 
KPO-5084 AAAAAAAGAGCGAGCTATTTAAAC In-vitro VadR 
KPO-5442 AGAGGTACCGGTTGTTAACGGCTTAGATCTAAAGTTCAAAAAATCAG pNP-132 
KPO-5443 GCTGTCTTTGTTTGGTCTGAG pNP-132 
KPO-5444 TCAGACCAAACAAAGACAGCGACTACAAAGACCATGACGGTG pNP-132 
KPO-5445 ATCGTTGGATTTTTGTGCGGTTACTATTTATCGTCATCTTTGTAGTC pNP-132 
KPO-5446 CCGCACAAAAATCCAACGATTTC pNP-132 
KPO-5447 TATGCATCCTAGGCCTATTAGCAGCAATACTTCAACCGGAG pNP-132 
KPO-5450 AGAGGTACCGGTTGTTAACGGAGCTCAATAAGCGAGGAATTC pNP-134 
KPO-5451 GAAATATGCAAGCTGAGTTTTCC pNP-134 
KPO-5452 AAACTCAGCTTGCATATTTCGTCGGAATTCACAAACCTGTC pNP-134 
KPO-5453 TATGCATCCTAGGCCTATTAGAATGGTCTGATCGGAGGTG pNP-134 
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KPO-5456 AGAGGTACCGGTTGTTAACGGAACGTACTTTGATTGGAAAAACC pNP-128 
KPO-5457 TATGCATCCTAGGCCTATTACTTCTTTCGATACGGTGACTTG pNP-128 
KPO-5458 GTTTCAGTTTCCCACTTTATGTGGCTAAAC pNP-129 
KPO-5459 GAAACTGAAACTTTTGACAGCTTTGTAGATAG pNP-129 
KPO-5534 GTTTTTATGCATCAAATAATGATGATTAGCCGTCAA G pRH-090 
KPO-5535 GTTTTTGCTAGCGTTCGATGCCAAAGCGAGAG pRH-090 
KPO-5538 GTTTTTATGCATGTAAACTATTATGTCATCGAAACG pRH-092 
KPO-5539 GTTTTTGCTAGCCACCAAGTAAGAGAGTTCAGAG pRH-092 
KPO-5548 CCGCCGATACACTGCTTCACGAATACTGAACCTTTTGTCCTATC pRH-093 
KPO-5549 GATTTTGCCAAATCGTAGGCAAAAAAAGAGCGAGCTATTTAAACTC pRH-093 
KPO-5550 TTCAGTATTCGTGAAGCAGTGTATCGGCGGTTATTCGGTTC pRH-093 
KPO-5551 CTTTTTTTGCCTACGATTTGGCAAAATCCTGACTCAGTGC pRH-093 
KPO-5552 GAGCGAGCTATTTAAACTCGC VadR 3’ probe 
KPO-5692 GTTCAGTAACTTTAAAGGATCTATCATG pNP-120 
KPO-5693 GTTACTGAACCATTTGTTTTTACAACTG pNP-120 
KPO-5696 GTTACCGTATGAAGGTTAAAGGTTTATCAG pNP-119 
KPO-5697 CATACGGTAACTACGCACATGATTTAATATTG pNP-119 
KPO-5698 CAAGGTTTTGTCCTATCTGATGAATTG pNP-168 
KPO-5699 CAAAACCTTGTCTATTCCCACACATTA pNP-168 
KPO-5700 GTGGTATCTGATGAATTGTAGATTGG pNP-118 
KPO-5701 GATACCACAAAAGGTTGTCTATTCC pNP-118 
KPO-5743 GAACCAAAAAAGCAGAATACGCATTAC pNP-121 
KPO-5744 CTTTTTTGGTTCATCACTAGACGCTC pNP-121 
KPO-5835 TCGGCTCGTATAATGTGTGGGCGGGTAAAACGCAACTAATC pLS014 
KPO-5836 GCTCAATCAATCACCGGATCCCACCATTTTATGCTCTAGAAATG pLS014 
KPO-5837 TCGGCTCGTATAATGTGTGGGAGAGGTACATAAGAGTTCAAG pLS-015 
KPO-5838 GCTCAATCAATCACCGGATCCGATGTTTTAGGGATATAAAAATAG pLS-015 
KPO-5841 TCGGCTCGTATAATGTGTGGATATATTTCCCAAAGTGGGAAATAG pLS-016 
KPO-5842 GCTCAATCAATCACCGGATCGGAATTGATATGATGAAGACAGAAA pLS-016 
KPO-5843 TCGGCTCGTATAATGTGTGGAGAATCGTTGCTAATCCTGCG pLS-017 
KPO-5844  GCTCAATCAATCACCGGATCCAATGCTCAGTCGTTTGGGTAT pLS-017 
KPO-5845 TCGGCTCGTATAATGTGTGGCCCGAACAGTCTATTTTGCTATTC pLS-018 
KPO-5846 GCTCAATCAATCACCGGATCCCAATCACATAGTCTGCCTATGC pLS-018 
KPO-5847 TCGGCTCGTATAATGTGTGGAATTTGATTATTCTGAATAACCATTAC pLS-019 
KPO-5848 GCTCAATCAATCACCGGATCGTGACTTGCAACTCCGAGT pLS-019 
KPO-5849 TCGGCTCGTATAATGTGTGGGAACTCAGTAGAATCGCTTAGG pLS-020 
KPO-5850 GCTCAATCAATCACCGGATCGCACCATTTTACCGTGGTTTAG pLS-020 
KPO-5981 GTTTTGTTAAACCTGACAACAGTCTGAC pLS-026 
KPO-5982 GTTTAACAAAACCAACGCCCAGCC pLS-026 
KPO-5983 AAACCAACAGTCTGACATTGAACCGAATAAC pLS-027 
KPO-5984 CTGTTGGTTTAAGTCACAAAACCAACGC pLS-027 
KPO-5985 CAGTCATTGAACCGAATAACCGCCG pLS-028 
KPO-5986 TCAATGACTGTTGTCAGGTTTAAGTCAC pLS-028 
KPO-6013 CAACTCTCTACTGTTTCTCC GCTTAGATCTAAAGTTCAAAAAATC pRH-099 
KPO-6014 TATGCATCCTAGGCCTATTA GTTCGCCCACTGTTTATCTTG  pRH-099 
KPO-6015 GGGTCTTTTATGATCTTATA CGTTTTGAAGCAATTTGAGATACC pRH-099 
KPO-6016 AGAGGTACCGGTTGTTAACG GTAGTCACTAGGGTTTTGTCATC pRH-099 
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